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 Bacteria have developed resistance mechanisms to every class of antibiotics that has been 
created and combating the rise of multidrug-resistant bacteria—a major threat to public health—
requires the continual development of novel antibacterial agents. Gram-negative bacteria are 
particularly difficult to target due to their dual-membrane cell envelope and highly impermeable 
outer membrane. Essential proteins at or near the cell surface of bacteria are therefore potential 
targets for novel antibiotic development.  We sought to probe the mechanisms and structural 
details of two such essential bacterial proteins: the β-barrel assembly machine (Bam) of 
Escherichia coli and penicillin-binding protein 2 (PBP2) of Staphylococcus aureus. 
Bam is a highly conserved five-protein complex that is situated in the outer membranes 
of Gram-negative bacteria, mitochondria, and chloroplasts.  In E. coli the Bam complex performs 
the essential function of folding and inserting transmembrane β-barrel proteins into the cell’s 
outer membrane. In Chapter 2, biochemical assays aimed at elucidating the process by which 
outer membrane proteins are delivered to Bam are described. We reconstituted the Bam complex 
and subcomplexes in vitro to examine the role of chaperone proteins in delivering unfolded outer 
membrane proteins to Bam. We demonstrated that two β-barrel protein substrates with large 
soluble periplasmic domains have the ability to fold on the complex independent of a chaperone. 
 In vitro biochemical experiments with the Bam complex cannot provide atomic-level 
mechanistic insight into how the complex binds, folds, and inserts transmembrane β-barrels into 
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the outer membrane. In Chapter 3, efforts toward obtaining a crystal structure of Bam are 
described. Structures of the five Bam proteins had been solved individually, but the structure of 
the Bam complex or a Bam subcomplex had not been reported. We successfully crystallized Bam 
subcomplexes and made progress toward obtaining a crystal structure of this macromolecular 
machine. 
 In Chapter 4, we report the use of a fluorescence displacement assay to identity putative 
small molecule inhibitors of the S. aureus PBP2 protein. PBP2 catalyzes the essential 
transglycosylation and transpeptidation steps in the synthesis of the bacterial cell wall and is 
therefore an attractive target for novel antibiotics. We report progress toward the cocrystallization 
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1.1: Gram-negative bacteria and antibiotic resistance 
In 1884, Hans Christian Gram published a novel method for staining bacteria using the dye 
crystal violet. Although Gram was interested in identifying bacterially-infected lung tissue and 
not classifying bacteria, his staining technique led to the division of bacteria into two groups: 
Gram-negative and Gram-positive bacteria.1 Electron micrographs obtained in the 1960s revealed 
marked structural differences between these two families of bacteria.2  
 
A distinguishing feature of Gram-negative bacteria is the presence of a second lipid bilayer, the 
outer membrane (OM), which resides exterior to the cell’s inner membrane (IM).  The IM is a 
symmetric bilayer composed of phospholipids, while the OM is an asymmetric bilayer. The inner 
leaflet of the OM consists of phospholipids and the outer leaflet of the OM is composed of 
lipopolysaccharide (LPS), a hexa-acylated polysaccharide that acts as a permeability barrier, 
preventing easy access of small molecules into the interior of the cell.3,4 An aqueous compartment 
known as the periplasm separates the IM from the OM and contains a thin layer of peptidoglycan 
(PG), a heavily-crosslinked polymer consisting of sugars and amino acids that is responsible for 
maintaining the integrity of the cell’s shape during osmotic stress. Together, the IM, OM, and 
periplasm constitute the cell envelope. Gram-positive bacteria, as opposed to Gram-negative 
bacteria, have a single cell membrane that is composed of phospholipids and a thick, extracellular 
layer of peptidoglycan. Greater binding of crystal violet to the thick cell wall of Gram-negative 
bacteria causes the stain to be retained, while the layer of peptidoglycan in Gram-negative 
bacteria is too thin to retain the dye.5  
 
The cell membrane of Gram-positive bacteria and the IM of Gram-negative bacteria contain 
transmembrane α-helical bundle proteins and membrane-associated lipoproteins, while the OM of 
Gram-negative bacteria contains membrane-associated lipoproteins and transmembrane β-barrel 
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proteins. Altogether, these proteins are responsible for the essential functions of maintaining the 
integrity of the cell’s shape, assembling the membrane, transducing signals into the cell, 
transporting molecules into and out of the cell, and—importantly in the context of this research—
folding and assembling transmembrane proteins. 
Resistance mechanisms to all classes of clinically useful antibiotics have emerged, often within a 
decade of an antibiotic’s development.6-11 This arms race between bacteria and chemists requires 
the continual development of new classes of antibiotics. And while new antibiotics that target 
Gram-positive bacteria have been developed in recent years, the latest class of antibiotic to treat 
Gram-negative infections, the quinolones, was developed in the 1960s.12 Although classifying 
bacteria based on their response to crystal violet is not a perfect system, understanding the 
structural differences between Gram-positive and Gram-negative bacteria helps to explain why 
the Gram-negatives are more resistant than their Gram-positive cousins. The greater number of 
membranes that separate a Gram-negative cell’s exterior from its interior and the presence of LPS 
in the OM, which, through its extended polysaccharide exterior and its hydrophobic, membrane-
bound core, creates a barrier to both hydrophobic and hydrophilic molecules. Additionally, LPS 
molecules in the OM are bridged with divalent cations, a feature that decreases the fluidity of the 
OM and reduces the membrane’s permeability. Compared to a lipid membrane composed entirely 
of phospholipids, the outer membrane of Gram-negative bacteria is two orders of magnitude less 
permeable to small molecules, rendering antibiotics that effectively kill Gram-positive 
ineffective.13,14 
 
Creating variants of existing antibiotics that can circumvent resistance mechanisms and 
identifying targets for new antibiotics are the two approaches for combating antibiotic resistance. 
Due to their proximity to the exterior of the cell and the greater ease by which small molecules 
can access their features, essential components in the outer membrane of Gram-negative bacteria 
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are well-suited as drug targets. Here, biochemical and structural studies of an essential E. coli 
outer membrane protein (OMP) complex, the β-barrel assembly machine (Bam) are described. 
The Bam complex is composed of five proteins, BamABCDE, which are responsible for the 
folding and insertion of transmembrane β-barrel proteins into the outer membrane of Gram-
negative bacteria. Chapter 2 describes biochemical experiments that probe the roles of individual 
Bam proteins and Bam protein subcomplexes in the assembly of OMPs. Chapter 3 describes 
structural studies of the Bam complex. Finally, chapter 4 describes work toward the 
cocrystallization of an essential extracellular protein from Staphylococcus aureus with small 
molecule inhibitors. The latter system is outlined in the introduction to chapter 4. This chapter 
describes outer membrane biogenesis and the role of the Bam complex in the assembly of OMPs. 
 
1.2: Outer membrane biogenesis 
The assembly of outer membrane components presents a challenge to Gram-negative cells 
because there is no energy source in the periplasm, such as ATP, to drive biochemical processes. 
Instead, energy from the cytoplasm must be used to transport and to assemble lipoproteins, IM 
proteins (IMPs), OMPs, LPS, phospholipids, and the cell wall. Many of proteins that aid in these 
transport and assembly processes have been identified and biochemically characterized in recent 
years.15-20 IMPs are assembled by a conserved α-helical bundle know as the secretion (Sec) 
machine, which is also responsible for the secretion of lipoproteins and nascent OMPs into the 
periplasm. Three pathways are at the heart of OM biogenesis: 1) the localization of lipoproteins 
(Lol) pathway is responsible for the maturation and transport of lipoproteins in the cell envelope, 
2) the lipopolysaccharide transport pathway is responsible for the delivery and insertion of LPS 
into the OM, and 3) the β-barrel assembly machine carries out the final steps of OMP assembly in 
the OM (Figure 1.1).  Despite progress in identification of the protein machinery involved in 
these three pathways, the mechanism by which phospholipids reach the OM remains a mystery. 




Figure 1.1. Three pathways are responsible for the biogenesis of lipoproteins, 
OMPs, and lipopolysaccharide. Lipoproteins and OMPs are synthesized 
ribosomally in the cytoplasm, directed to the cell envelope by an N
signal sequence, and transported in an ATP
periplasm. Lipoproteins are lipidated and those destin
trafficked by LolA and inserted into the OM by LolB. After their transport 
through Sec, periplasmic chaperones receive nascent OMPs and deliver them to 
the Bam complex, which folds them and inserts them into the OM. The Lpt 
pathway transports LPS to the OM. MsbA transports LPS across the IM in an 
ATP-dependent fashion and the LptBCFG IM complex transfers the LPS to a 
periplasmic bridge composed of LptA. The outer membrane complex LptDE 
receives LPS from LptA and inserts it into the outer l
courtesy of Suguru Okuda.
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1.3: Lipoprotein transport 
All proteins that reside in the cell envelope—OMPs, IMPs, and soluble periplasmic proteins—are 
synthesized in the cytoplasm. Trafficking of these proteins to their final locations relies on an N-
terminal signal sequence, which directs them to the secretory machinery, Sec. Lipoproteins are 
distinguished by a lipobox motif that immediately follows the N-terminal secretion signal 
sequence. Upon secretion into the periplasm, the lipobox motif binds with Lgt, a protein that 
covalently attaches diacylglycerol moiety to a cysteine residue just C-terminal to the signal 
sequence. LspA, a peptidase specific to the maturation of lipoproteins, cleaves the signal peptide 
on the lipoprotein peptidase and the now N-terminal cysteine residue is modified with three fatty 
acyl tails by the enzyme Lnt.21,22 
 
The essential LolABCDE system is responsible for transporting mature lipoproteins from the 
outer leaflet of the inner membrane to the inner leaflet of the outer membrane. Upon cleavage of 
the N-terminal signal sequence and the appending of fatty acyl chains to the N-terminal cysteine 
residue, lipoproteins are ready to be directed to stay in the IM or to be transported to the OM. 
Lipoproteins that are to remain in the IM and those that are destined for the OM are distinguished 
by the two residues on the C-terminal side of the triacylated cysteine. In E. coli, the primary 
determinant of IM retention is the residue immediately C-terminal to the N-terminal cysteine.23,24 
Asp is nearly always the amino acid in this position in E. coli. The amino acid in the third 
position determines whether the protein remains in the IM or is directed to the OM. An Asn, Glu, 
Gln, or Asp residue in this position increases the propensity of the protein to remain in the IM, 
while a Lys or His in this position direct the lipoprotein to the OM.25 
 
Removal of the lipoprotein from the IM is catalyzed in an ATP-dependent fashion by the protein 
complex LolCDE that form a 1:2:1 complex. LolC and LolE form a transmembrane α-helical 
heterodimer and the LolD dimer resides in the cytoplasm. LolD contains an ATP-binding 
7 
 
cassette, which is responsible for coupling ATP hydrolysis to the transport of lipoproteins across 
the periplasm.26 Lipoproteins that are to be trafficked to the OM are transported via the soluble 
periplasmic chaperone protein LolA. The transfer of a lipoprotein to LolA is carried out by 
LolCDE in an ATP-dependent fashion. Transporting lipophilic molecules through the aqueous 
periplasm presents a challenge for cells, which must shield the fatty acyl tails of OM lipoproteins. 
The periplasmic protein LolA binds to the hydrophobic tails of transiting lipoproteins, thereby 
preventing the energetically unfavorable exposure of these tails to water and preventing the 
aggregation of lipoproteins. Once loaded onto LolA, the lipoprotein makes its way to the outer 
membrane protein LolB. LolB is a lipoprotein that, like LolA, contains a hydrophobic pocket for 
binding the acyl tails of a transiting lipoprotein. Finally, LolB releases the transiting lipoprotein 
into the inner leaflet of the OM. The transfer of a lipoprotein to LolA and the insertion of a 
lipoprotein into the OM by LolB must be energetically favorable, as there is no energy source in 
the periplasm. 
 
1.4: Lipopolysaccharide transport to the OM 
LPS synthesis occurs in the inner leaftlet on the IM and more than 100 genes are required for its 
biogenesis.27 Many of these genes have been identified as viable targets for antibiotics since 
mature, correctly formed LPS is necessary to maintain the integrity of the OM and to ensure that 
the OM is impermeable to potentially deadly small molecules.28 The biosynthetic pathway of LPS 
has been well studied and almost entirely reconstituted in vitro.29,30 Once synthesized, the IM 
transmembrane protein MsbA flips LPS from the inner leaflet of the IM to the outer leaflet of the 
IM using the hydrolysis of ATP to drive the transport.31-33 At this stage, LPS is much shorter than 
the form that is present in the OM upon maturation. O-antigen, a cytotoxic polymer of up to 200 




The transport of LPS from the IM to the OM depends on a seven-protein complex, 
LptABCDEFG, all of which are essential for the viability of E. coli. LptBCFG comprise a 
complex in the IM that is responsible for the initial stages of transport and are present in a 2:1:1:1 
ratio. Upon flipping to the outer leaflet of the IM, LPS associates with the single-pass 
transmembrane protein LptC, which contains a periplasmic C-terminal domain that adopts a β-
jellyroll fold, the interior of which shields the hydrophobic regions of LPS from the aqueous 
periplasm.35,36 LptB forms a homodimer, which resides in the cytoplasm and contains two 
nucleotide binding domains at the dimer interface. The LptB dimer binds to the LptFG complex, 
a transmembrane α-helical dimer, via two coupling helices on LptFG.37,38 
 
The energy released from the hydrolysis of ATP by LptB is used to shunt LPS from its binding 
site on LptC onto a periplasmic bridge composed of multiple molecules of LptA. Like LptC, 
LptA adopts a β-jellyroll fold to shield hydrophobic regions of LPS during its transit across the 
periplasm. LptA delivers LPS to the periplasmic, N-terminal domain of the OMP LptD, the C-
terminus of which is a transmembrane β-barrel. LptA and LptC belong to the same OstA family 
as the N-terminal domain of LptD and structural studies of LptD indicate that its N-terminal 
domain also adopts a β-jellyroll fold.39,40 Crystal structures of LptA reveal that the protein forms 
multimeric fibrils, with the β-jellyrolls of one LptA molecule aligning and forming contacts with 
the β-jellyroll folds of adjacent LptA proteins. These multimers form a continuous hydrophobic 
tunnel through which LPS makes its way to the OM (Figure 1.2). Creative biochemical assays 
revealed additional details of the intriguing periplasmic journey of LPS. Photocrosslinking studies 
by Okuda et al. determined that the Lpt proteins form a transenvelope bridge that connects the IM 
LptBCFG complex to the OM LptDE complex via LptA.41 The unnatural amino acid p-
benzoylphenylalanine (pBPA) was encoded at specific sites within LptA, LptC, and the N-
terminal domain of LptD. UV-induced crosslinks formed between LptA and LptC, as well as 
between LptA and the N-terminal domain of LptD, supporting the model of a transenvelope Lpt 
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bridge.42 Using a similar technique, Okuda et al. determined that LPS binds to the hydrophobic 
cores of LptA, LptC, and the N-terminal domain of LptD. These experiments demonstrated that 
multiple rounds of ATP hydrolysis by LptB are required for LPS transport onto LptA, suggesting 
that transit of LPS across the periplasm is driven by enzymatic activity in the cytoplasm. It is 
believed that LPS is transported in a continuous stream, where the hydrolysis of ATP by LptB 







The final stage of LPS insertion into the OM is performed by LptDE, a 1:1 heterodimer. LptD is 
composed of an N-terminal periplasmic domain belonging to the OstA superfamily and that, like 
LptA and LptC, adopts a β-jellyroll fold. The C-terminal domain of LptD is a transmembrane β-
barrel containing 26 anti-parallel β-strands. It is the largest transmembrane β-barrel protein 
identified to date.44 LptE is a lipoprotein that is anchored to the inner leaflet of the OM. 
Proteolysis of purified LptD and LptE showed that LptD protects LptE from degradation, 
suggesting the LptE acts a plug to the LptD barrel.45 Site-specific photocrosslinking experiments 
using pBPA provided more evidence for this hypothesis, with one crosslink forming between 
LptE and an extracellular loop of LptD.46 Dong et al. reported the crystal structure of the LptDE 
complex in 2014, which confirmed this plug and barrel tertiary structure.44 From this work, the 
Figure 1.2. The crystal structure of LptA fibrils reveals an end-to-end 
assembly wherein neighboring β-jellyroll folds align, forming a 
continuous hydrophobic tunnel that aids in the transit of LPS from the 
inner membrane to the outer membrane. Figure from ref. 35 
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following mechanism of LPS transport across the periplasm has been proposed: LPS is directly 
transferred from LptC in the IM to LptA, which transfers LPS to the N-terminal domain of LptD. 
The LptDE complex then flip LPS to the outer leaflet of the OM without LPS ever entering the 
inner leaflet of the OM.47  
 
1.5: Outer membrane protein biogenesis 
The third pathway of cell envelope biogenesis is the synthesis, transport, and assembly of 
transmembrane β-barrel proteins that reside in the outer membrane. This section addresses 
common features of all transmembrane proteins, how OMPs are directed to the outer membrane, 
and past work on the protein complex responsible for folding and inserting OMPs into the outer 
membrane, the Bam complex. 
 
1.5.1: Transmembrane proteins 
In all living organisms, transmembrane proteins adopt either an α-helical bundle structure or a β-
barrel structure.48 Most transmembrane proteins are α-helical bundles, which are present in the 
cell membranes of eukaryotes and Gram-positive bacteria, as well as the IM of Gram-negative 
bacteria.49,50 Transmembrane β-barrels, though less abundant than α-helical bundles, have also 
been conserved through higher organisms. They are present in the outer membranes of Gram-
negative bacteria, chloroplasts, and mitochondria.48 Just as α-helical bundle proteins are 
segregated from transmembrane β-barrel proteins, the protein machines that assemble 
transmembrane proteins are segregated in the cell. The protein machinery responsible for folding 
and inserting transmembrane α-helical bundles, Sec, is itself an α-helical protein that resides in 
the IM. Likewise, the protein machinery that carries out the folding and insertion of 
transmembrane β-barrel proteins is positioned in the membrane into which its substrates 




In their final, folded forms, the transmembrane regions of integral membrane proteins reside in a 
hydrophobic lipid bilayer. Exposing any hydrophilic moieties to this lipidic environment would 
incur a large energetic cost, so the transmembrane domains of integral membrane proteins must 
sequester polar amino acid side chains and their polar amide backbones from their hydrophobic 
surroundings. Transmembrane proteins solve the latter problem by forming hydrogen bonds 
internally along the length of the protein backbone or between distal regions of their 
transmembrane domains. In the case of α-helical bundle proteins, hydrogen bonds form between 
nearby residues to form α-helices, which are independently stable and assemble into bundles. In 
the case of beta-barrel proteins, hydrogen bonds form between distal residues in the form of β-
sheets. Only when an extended β-sheet folds back on itself to form a cylinder will all hydrogen 
bonding partners be satisfied, which introduces a bit of a problem. If a β-barrel were to fold in a 
hydrophilic environment, the hydrophobic effect would dictate that the barrel would fold inside 
out, placing hydrophilic residues on the protein’s surface. Likewise, a β-barrel cannot be inserted 
into the membrane unfolded since exposed unsatisfied hydrogen bonds would be too much of an 
energetic cost. It is therefore believed that the folding and insertion of transmembrane β-barrels is 
a coordinated process, though the mechanism by white this assembly process takes place has not 
been fully elucidated. 
 
1.5.2: Transporting OMPs to the OM 
All proteins that exist in the periplasmic space, the IM, or the OM, are initially synthesized on 
ribosomes in the cytoplasm. An N-terminal signal sequence directs these proteins to the secretory 
machinery, the Sec complex, which resides in the IM and is composed of the proteins 
SecAYEGDF. The transportation of all IMPs, periplasmic proteins, lipoproteins, and OMPs into 
the periplasm is performed by the Sec complex in an ATP-dependent fashion and SecA is the 
ATPase responsible for harnessing the energy of ATP hydrolysis.51-53 IMPs are co-translationally 
targeted to the Sec machine via a nucleic acid-protein complex called signal recognition particle 
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(SRP), which binds to an IMP’s signal sequence as it emerges from the ribosome and delivers the 
IMP-ribosome species to Sec. In contrast, OMPs are targeted to Sec post-translationally. A 
protein called trigger factor (TF) outcompetes SRP for binding the N-terminal secretion signal 
sequence and recruits the chaperone protein SecB to the OMP as it emerges from the ribosome.54-
59
 SecB, like periplasmic chaperones of hydrophobic proteins, occludes the hydrophobic regions 
of unfolded OMPs from the cytoplasm. 
 
The final, folded forms of IMPs and OMPs are energetically more stable than their unfolded 
forms, but the uncatalyzed folding of these proteins proceeds too slowly and is unable to be 
regulated by cells. Therefore, protein complexes aid in the assembly of transmembrane proteins. 
After IMPs are targeted to Sec, it is believed that individual α-helices assemble within the core of 
the transmembrane SecYEG complex, driven by the energy released during protein synthesis on 
the ribosome.50,60 The α-helices are then secreted one-by-one into the IM through a lateral gate in 
Sec, where their hydrophobic exteriors interact more favorably with their hydrophobic 
surroundings than they would in an aqueous environment.52 As the α-helices emerge from Sec, it 
is believed that they assemble with one another into bundles and release themselves from the Sec 
machinery. This entire process prevents hydrophilic sidechains or the polar backbone of an IMP 
from being exposed to water at any point in its transport and insertion into the IM. 
 
OMPs are transported through the IM using the energy released from the ATPase activity of 
SecA.61 Because they must transit the periplasm and are not assembled until reaching the OM, 
OMPs are released from Sec in an unfolded state. These proteins must remain in a folding-
competent state, they cannot be allowed to misfold in the periplasm, and their aggregation must 
be prevented as they leave the Sec machinery, so periplasmic chaperone proteins assist in OMP 
delivery to the OM. Since no ATP is available in the periplasm, the protection of OMPs during 




Two pathways have been discovered that are responsible for chaperoning OMPs from their 
emergence from Sec to the OM. SurA, a periplasmic chaperone, is responsible for aiding in the 
transit of the majority of OMPs, while an alternative pathway involving the chaperones DegP and 
Skp has been shown to compensate for SurA activity when the gene encoding SurA is knocked 
out.62 Two additional periplasmic proteins, FkpA and PpiD, have been implicated in OMP 
chaperoning as well. However, deletions of these proteins does no result in decreased levels of 
assembled OMPs, suggesting that their role in chaperoning may be very limited.63,64 
 
Four domains comprise SurA, the most important chaperone involved in OMP transport. Its P1 
domain and its N- and C-terminal domains form the core of the protein, exhibiting a hydrophobic 
groove that is believed to be responsible for binding the hydrophobic portions of OMPs. This core 
of SurA resembles the hydrophobic core of trigger factor, suggesting that the two proteins 
evolved to recognize similar features of unfolded, hydrophobic transmembrane proteins.65 SurA’s 
P2 domain is linked to its P1 domain via extended linkers. This domain exhibits peptidyl-prolyl 
isomerase (PPIase) activity in vitro.66-69 The predominant OMPs of E. coli OmpA, OmpF, LamB, 
and OmpC, are chaperoned preferentially by SurA. When SurA is deleted from cells, the folded 
forms of these OMPs is reduced and cells exhibit membrane defects.68,70 
 
In addition to the important role played by SurA in OMP transport, several biochemical 
experiments have implicated an additional protein, Skp, as a chaperone for OMPs, though its role 
is not fully understood.  Skp is a trimeric protein that has been shown to bind unfolded OMPs.71 
In its folded state, the Skp trimer contains a large hydrophobic core large enough to envelop 
unfolded OMPs.72 Likewise, Skp has been shown to crosslink to the Sec machinery, suggesting 
that it plays an early role in the protection of OMPs as they enter the periplasm.73 Experiments 
involving the maturation of the OMP EspP have suggested that Skp and SurA collaborate to 
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transport EspP to the OM. EspP was shown to crosslink to Skp shortly after its emergence from 
Sec, while crosslinking at later timepoints resulted in an EspP-SurA crosslinked species.74 
Nevertheless, no experiments have been able to show a direct interaction between Skp and SurA. 
 
Like SurA, FkpA exhibits both PPIase and chaperoning activity. Nevertheless, its role in 
chaperoning unfolded OMPs to the OM has been shown to be much less important for cells than 
that of SurA.63,75 The deletion of FkpA by itself does not produce phenotypes consisted with 
flawed OMP assembly, but when FkpA is deleted in conjunction with SurA and two additional 
periplasmic chaperones, PpiD and PpiA, cells exhibit a greater sensitivity to antibiotics and do 
not grow as well as cells with single deletions of these genes. Together, these experiments 
suggest that FkpA is most relevant when cells are experiencing stress related to the accumulation 
of unfolded OMPs in the periplasm.  
 
The presence of misfolded or aggregated proteins in the periplasm is toxic to cells, so E. coli and 
other Gram-negative bacteria have evolved stress responses to degrade and to isolate these toxic 
species. The σE stress response is responsible for upregulating the expression of periplasmic 
chaperones when cell envelope stress develops.76-79 The expression of DegP, which displays 
proteolytic activity and chaperoning activity, is enhanced when unfolded proteins in the 
periplasm cause the cell stress. DegP is hexameric when unbound to an unfolded OMP and adopts 
a cage-like structure consisting of 12 or 24 monomers when bound to an unfolded OMP.80,81 
Upon entering the cage structure of DegP, an unfolded OMP is quickly degraded, after which the 
DegP complex disassembles.82 When in its hexameric form, DegP exhibits no protease activity. 
Although the protease activity of DegP suggests that the protein would not serve as a good 
molecular chaperone for unfolded OMPs, cryo-EM studies have shown that an unfolded protein 




1.5.3: Identification of the Bam complex 
After OMPs have been chaperoned to the OM, the β-barrel assembly machine, Bam, receives its 
unfolded substrates, folds them, and inserts them into the OM. The discovery of this complex 
occurred fairly recently and was in large part delayed due to the historical difficulty of identifying 
any OMPs. The majority of OMPs were first identified by fractionation experiments—outer 
membrane fragments were isolated from cells and the most abundant OMPs were identified quite 
readily. These include OmpA, OmpF, LamB, and OmpC. Less abundant OMPs avoided 
detection.  
 
When the search for the machinery responsible for the assembly of OMPs in E. coli began, only 
one outer membrane β-barrel protein, LptD, and one lipoprotein, LolB, had been identified as 
essential components of the OM.83-85 LptD, which carries out the final step of LPS transport to the 
OM, was discovered through genetic selections for proteins whose absence caused permeability 
defects in the outer membrane. Depletion experiments of LptD indicated that it was essential, 
which implied that the outer membrane protein or protein complex responsible for assembling 
LptD was also essential.17,86 Using the nucleotide sequence of Toc75, a transmembrane β-barrel 
present in the outer membrane of chloroplasts that had been implicated in protein import, a search 
was performed for homologues in bacteria. A gene in Neisseria meningitides, ultimately termed 
BamA, showed significant homology to Toc75 and was subsequently shown to have a role in 
transmembrane β-barrel assembly.87-90 Homology searches for the other chloroplastic membrane 
proteins implicated in β-barrel protein assembly did not turn up any additional matches in 
bacteria, suggesting that only BamA has been conserved. 
 
To search for additional proteins involved in the assembly of outer membrane proteins, a strain of 
E. coli expressing a defective copy of LptD was used to elicit mutations in membrane protein 
assembly-associated genes that would correct the defective LptD.91-93 Specifically, the cells 
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expressed the gene lptD4213, a variant of the LPS transporter that causes E. coli to have a leaky 
OM. This strain was grown in the presence of small molecule toxins that would kill the cells if 
they reached their targets in the periplasm. This approach, termed “chemical conditionality” had 
been used by Jacob and Monod in their studies of the lac operon.94 The result of this work by 
Ruiz et al. was the identification of a mutation in BamB, an OM lipoprotein, that restored the 
OM’s permeability barrier. Because small molecules can rely on alternative means of entering 
cells, it is possible to elicit diverse genetic mutations in the components affecting membrane 
permeability. 
 
The identification of BamB inspired affinity purifications in the hopes of revealing additional 
factors involved in the assembly of OMPs. BamB was determined not to be essential for E. coli, 
but as stated earlier, it was suspected that an essential protein central to OMP assembly existed. 
The results of these affinity purifications revealed that BamB associates with the 88.5 kDa outer 
membrane β-barrel protein BamA, which interacts with the lipoproteins BamC, BamD, and 
BameE.18,19,92 Additionally, affinity purifications in which a polyhistidine tag was placed on any 
one of the five components resulted in pulling down the entire five-protein complex. In addition, 
the complex can be run on a protein gel using blue native gel electrophoresis without dissociation 
of the complex.  
 
Depletion experiments showed that BamA and BamD are necessary for cell viability, while single 
deletions of BamB, BamC, and BamE cause defects in the assembly of OMPs and elicit the σE 
stress response without causing cell death.19,20,95,96 The essentiality of BamA and BamD suggest 
that these two proteins are largely responsible for the catalytic activity of the Bam complex. 
BamB, BamC, and BamE likely play accessory roles, perhaps in the selection of OMPs for 
assembly or as regulators of OMP assembly, though their in vivo functions are still unclear. 
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Together, BamABCDE comprise the essential OM complex responsible for transmembrane β-
barrel assembly in the OM of Gram-negative bacteria.  
 
1.5.4: Structural studies of the Bam complex 
BamA belongs to the Omp85 superfamily of transmembrane β-barrel proteins, a family that 
includes the BamA homologues present in chloroplasts and mitochondria, as well as β-sheet 
autotransporters, such as the OMP FhaC. This superfamily is distinguished by the presence of 
soluble polypeptide transport associated (POTRA) domains and a transmembrane β-barrel 
domain. In the case of E. coli BamA, there are five periplasmic POTRA domains on the protein’s 
N-terminus and a 16-strand β-barrel on the C-terminus. To determine how the four Bam 
lipoproteins associate with BamA, pull-down experiments were performed using POTRA domain 
deletions of BamA.97 These studies showed that BamB associates with POTRA domains P2-5, 
since deletions of those domains from BamA prevent copurification of BamB. When P5 is 
deleted from BamA, BamD, BamC, and BamE fail to copurify with BamA, suggesting that the 
three lipoproteins coordinate with BamA at that site. Single deletions of BamC or BamE do not 
prevent the copurification of BamD with BamA, but depletion experiments of BamD cause BamC 
and BamE not to associate with BamA, suggesting that BamD coordinates directly with P5 of 
BamA and acts as an intermediary in the coordination of BamC and BamE to the complex.20 
POTRA domains 2-5 have been shown to be essential in E. coli, but because BamB is 
nonessential and the other three lipoproteins associate with BamA through P5, POTRA domains 
2-4 likely play an essential role in the assembly of OMPs.97  
 
Kim et al. published the first two structures of BamA POTRA domains 1-4 that contained a 
fragment of P5. The structure suggests roles for these domains of BamA in OMP assembly. Each 
POTRA domain consists of about 75 residues, which are arranged into two anti-parallel α-helices 
that stack onto a three-stranded β-sheet. Each POTRA domain contains a hydrophobic core at the 
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interface of the α-helices and β-strand. In the crystal structure, the crystallized fragment of P5 
folds back to P3 and extends the three-stranded β-sheet of P3 by an additional β-strand. Kim el al. 
interpreted this finding as evidence of a possible mechanism of Bam’s recognition of OMP 
substrates, a process that has been termed β-augmentation.98 This mechanism has been observed 
in the machinery that senses unfolded OMPs that arise during cell envelope stress.99 Additionally, 
both the β-augmentation observed in the BamA POTRA domain crystal structure and the β-
augmentation between unfolded OMPs and their sensors rely only on β-sheet secondary structure, 
with no readily identifiable selection for a specific sequence. This is not surprising in the case of 
BamA, which is known to handle dozens of OMP substrates. Finally, the two structures published 
by Kim et al. showed two distinct conformations of the POTRA domains, with one structure 
displaying a linear arrangement of the POTRA domains and the other exhibiting a pronounced 
bend in the linker region between P2 and P3. Because the Bam complex likely manipulates its 
substrates on a large scale—the final β-strand must be coordinated with the first β-strand in order 
to complete the β-barrel—perhaps this flexible linker in the POTRA domains facilitates large-
scale movements of OMPs during the folding process. 
 
More recently, Noinaj et al. published two structures of BamA: one from Neisseria gonorrhoeae 
containing all five POTRA domains and another from Haemophilus ducreyi lacking P1-3 (Figure 
1.3).100 The crystal structures showed that the interior of the BamA β-barrel is nearly empty with 
a volume of ~13,000 Å3. Extracellular loops form a dome-like structure on the extracellular face 
of BamA in both structures, which may prevent the influx or efflux of small molecules. Though 
the two structures bear many similarities, they also exhibit several differences. In the N. 
gonorrheoaea structure, P5 sits closer to the BamA β-barrel and interacts with several 
periplasmic loops, while the three POTRA domains of the H. decreyi structure swing away from 
the β-barrel of BamA. In the latter structure, there are no interactions between P5 and periplasmic 
loops of BamA. These differences are consistent with the model of OMP assembly via large-scale 
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motions of the BamA POTRA domains, with particular flexibility in the POTRA domains. 
Another difference between the two structures is the orientation of a long, extracellular loop L6, 
which contains a conserved VRGF motif that has been shown to play a role in OMP assembly.101 
In both structures, the L6 loop stretches into the lumen of the BamA β-barrel and interacts with β-
strands 14-16 roughly 18 Å away from the periplasmic face of the OM. Mutagenic studies of the 
VRGF motif indicate that the motif is not essential for β-barrel assembly, but mutations in the 
loop result in growth defects and fewer colonies than wild-type BamA. Finally, the H. ducreyi 
shows a closed β-barrel with eight hydrogen bonds stabilizing the interaction between strands 1 
and 16, where the β-barrel closes. In the N. gonorrheoaea structure, on the other hand, the C-
terminal β-strand is bent back into the β-barrel, forming only two hydrogen bonds with the N-
terminal strand. This is an unprecedented fold and a v-shaped gap created on the periplasmic face 
where the two strands meet suggests a mechanism whereby β-hairpins of a folding OMP emerge 
into the OM through a lateral gate in the BamA β-barrel, in a similar fashion to the gating 






















Figure 1.3. The structure of BamA from N. gonorrheoaea. POTRA domains 1-
5 are labeled P1-5, the β-barrel domain is labeled “β,” and the location of the 











X-ray crystal structures of
reported, but the individual structures are not particularly informative about the roles of the 
lipoproteins in OMP assembly (Figure 1.4).
the β-strands of which have been implicated in binding OMPs via 
than those simple features, ver
reported a crystal structure of BamC, a 34.3 kDa protein, in complex with BamD, a 25.8 kDa 
protein. The structure revealed that BamC consists of two globular domains and an extended loop 
that interacts along the length of BamD. BamD consists of ten 
tetracopeptide repeats (TPRs).
interactions and it has been proposed that a pocket formed by the first three TPRs of BamD may 
Figure 1.4. A. The structure of BamB is colored blue to red from the  N
terminus to the C
propeller. (pdb: 3prw) 
complex with one another. BamC consists of two globular domains and displays 
an extended loop that interacts along the length of BamD. BamD consists of 
five TPR domains, suggesting a role in binding unfolded OMPs. (pdb: 3tgo) 
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serve as a binding site for unfolded OMPs as they reach the Bam complex. The extended loop of 
BamC partially occludes this pocket of BamD, which suggests that BamC could play a regulatory 
role, controlling which substrates interact with BamD. Lastly, BamE is a small globular protein 
with a mass of 10.3 kDa. In BamE, two α-helices pack against a three-sheet β-strand. Other than 
these simple features, the role of BamE in OMP assembly is not understood.  
While the studies presented in this thesis were being conducted, two crystal structures of the four-
protein BamACDE complex were reported by Gu et al. and Bakelar et al.109,110 These structures 
demonstrate the orientation that the Bam lipoproteins adopt with respect to the BamA barrel and 
suggest a model for how OMP assembly occurs in vivo. This structure and its mechanistic 
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2.1 The power of reconstituting Bam function in vitro 
Due to the essentiality of BamA and BamD in the assembly of transmembrane β-barrel proteins, 
studying the function of the Bam complex in vivo presents challenges. Deletions of either 
essential component breaks the OMP-folding machine, leading to cell death, while deletions of 
BamB, C, or E result in impaired OMP assembly and the induction of the σE stress response.1-4 
Similarly, in vivo experiments have not been able to elucidate fully the role of periplasmic 
chaperones in the delivery of OMPs to the OM. SurA has been shown to crosslink BamA in vivo 
in a BamB-dependent fashion.5 A SurA and BamB double deletion strain of E. coli exhibits 
severe growth defects and since single deletions of either protein cause similarly reduced rates of 
OMP assembly, it is presumed that the two proteins may play comparable roles in the pathway.6 
Although it is possible to assess levels of OMP assembly in vivo by fractionating cells and 
isolating OMPs from the outer membrane, it is not possible to determine the roles of individual 
Bam components due to the pleiotropic effects of deletions or depletions of any of the Bam 
proteins. An in vitro reconstitution of OMP assembly by the Bam complex gives the researcher 
total control over the components in an assembly reaction. Through in vitro reconstitution 
experiments, it is possible to identify the minimal components of OMP assembly, which in theory 
could include cell envelope proteins that do not associate stably with any of the five Bam 
proteins. Additionally, an in vitro reconstitution of  Bam activity can be used to probe the roles of 
individual Bam proteins in the folding and insertion of OMPs. 
 
2.2: Initial overexpression, purification, and reconstitution of Bam activity 
The overexpression and purification of BamABCDE was first reported by Kim et al. in 2007.7 
The strategy for obtaining good yields of the complex relied on the knowledge that BamB 
associates with BamA at a distinct location from that of BamCDE. BamB associates with POTRA 
domains P2-5 of BamA, and BamC, BamD, and BamE coordinate BamA through P5-BamD 
interactions.4 BamA and BamB were expressed in a single strain of E. coli, cells were lysed, and 
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pelleted membrane fractions were dissolved in detergent. A second strain of E. coli overexpressed 
BamCDE-His, which was purified from the OM in the same manner as BamAB. The two 
solutions of Bam proteins were mixed and a polyhistidine tag on the C-terminus of BamE was 
used to pull down the whole complex using nickel affinity chromatography. Amino acid contents 
of the complex were determined quantitatively, indicating that the complex was comprised of 
BamABCDE in a 1:1:1:1:1 molar ratio. In addition, the complex was shown to form a stable 
assembly that runs on a blue native electrophoretic gel as a single band. 
 
Acquiring a high yield of Bam proteins from overexpression strains enabled efforts to reconstitute 
Bam activity in vitro, which was first reported by Hagan et al. in 2010.8 Prior to Bam’s in vitro 
reconstitution, the minimal components of OMP assembly were unknown. The in vitro 
reconstitution of Bam had to address several challenges. First, the absence of periplasmic 
components necessary for Bam activity or the loss of activity upon removing Bam from its native 
environment could easily prevent any OMP formation at all.  Second, the propensity of β-barrels 
to aggregate in aqueous environment also posed a challenge for the detection of a correctly folded 
OMP substrate. The in vitro assay for OMP assembly relied on techniques that had been 
developed to reconstitute the activities of other transmembrane proteins, such as the IM Sec 
machinery.9-13 Purified Bam complexes dissolved in detergent micelles were rapidly diluted in the 
presence of E. coli phospholipids, a process that reduces the detergent concentration below its 
critical micelle concentration and forces the dissolved proteins into phospholipid liposomes.14 
These liposomes were exposed to an unfolded substrate and the Bam complex assembles them 
into the liposomes. Importantly, the substrate must access the assembly machinery before it 
aggregates, a problem that was solved by dissolved OMP substrates in an 8 M solution of urea. 
Alternatively, urea-denatured OMPs could be incubated with a periplasmic chaperone prior to its 




The first reported OMP to be assembled using the in vitro reconstitution was OmpT, an 
enzymatic β-barrel that exhibits proteolytic activity when folded into a membrane (Figure 2.1).8 
OmpT was chosen because even if the majority of the OMP aggregated or failed to fold on Bam, 
it was possible to detect small amounts of its folded form by virtue of its enzymatic activity. 
OmpT recognizes peptides that contain several consecutive basic amino acids and a fluorogenic 
peptide substrate had been developed to monitor OmpT activity.15 Proteoliposomes containing the 
full BamABCDE complex or Bam subcomplexes BamAB or BamACDE were prepared. OmpT 
was preincubated with the periplasmic chaperone SurA, exposed to the proteoliposomes, and 
OmpT activity was monitored by fluorescence. The experiment showed that OmpT folded on all 
of the complexes, but when faced with empty liposomes, OmpT self-insertion occurred at a 
negligible rate. The BamAB complex, perhaps not too surprisingly, folded OmpT at the slowest 
rate, BamACDE folded the substrate slightly faster, and the full Bam complex assembled OmpT 
at the greatest rate. In the case of OmpT, the minimal components for successful assembly were 
thus BamA and SurA. The Bam proteoliposomes were also found to act catalytically by showing 
a greater extent of OmpT folding when additional amounts of SurA-OmpT were added to the 
folding reactions, demonstrating turnover. While it is not known what proportion of Bam 
complexes in the proteoliposomes are active, work with a reconstitution of the Sec machinery 













Not all OMPs are enzymes with a well-developed activity assay, so an alternative means of 
detecting OMPs folded in vitro was desired. Transmembrane β-barrel proteins retain a folded β-
barrel in the presence of many denaturants, which allowed for a gel-based folding assay to be 
developed. Boiling a β-barrel in SDS sample buffer denatures the protein entirely, but SDS by 
itself cannot disrupt the β-barrel, a property called heat-modifiability. Therefore, semi-native 
SDS-PAGE allowed for the separation of folded from unfolded forms of an OMP by virtue of 
their folding state. The folded form of an OMP is more compact than its unfolded form, usually 
resulting in its faster passage through a polyacrylamide gel. Immunoblotting of refolding 
reactions allowed for semi-quantitative measurements of the extent of OMP assembly from in 
vitro folding reactions. 
 
2.3:  The Bam complex assembles BamA in vitro 
The Bam complex is responsible for the folding of outer membrane β-barrel proteins and because 
BamA is itself a β-barrel, the complex has the rare property of being a machine that assembles 
itself. This has been further demonstrated in depletion studies of the Bam complex, which showed 
that Bam complexes already present in the OM assemble the β-barrels of additional BamA 
Figure 2.1. OmpT assembly by the Bam complex in vitro. A. SurA has a 
positive effect on OmpT assembly only when the Bam complex is present. B. 
The full Bam complex assembles OmpT much more efficiently than Bam 
subcomplexes. Figure adapted from ref. 8. 
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proteins.17 The two other dominant machines in E. coli that are known to assemble themselves are 
the secretory machinery of the IM and the ribosome. Although the ribosome has long been 
understood as a ribozyme, ribosomal proteins are necessary for efficient protein synthesis by 
interacting with intermediate forms of RNA during polypeptide extension.18-21 In the case of 
SecAYEG, the SecA translocon has been specifically implicated in the assembly of 
transmembrane α-helical proteins.22 The self-assembly properties of these systems present a 
chicken and egg problem and raise questions about the first forms of the systems and how they 
evolved to their current forms. Addressing these questions by studying the proteins’ activities in 
vivo is difficult due to the proteins’ essentiality. To study the roles of individual Bam components 
in BamA assembly, we were therefore interested in reconstituting the assembly of BamA in vitro. 
 
The Bam complex or Bam subcomplexes were incorporated into liposomes and a urea-denatured 
FLAG-tagged BamA substrate was incubated in 8 M urea, TBS pH 8.0, or 50 µM SurA for ten 
minutes prior to exposure to the liposomes (Figure 2.2).23 After 60 minutes, the reactions were 
quenched with SDS sample buffer and reaction products were separated on semi-native SDS-
PAGE. Immunoblotting with α-FLAG-HRP antibodies showed that the BamABCDE, BamAB, 
and BamACDE complexes successfully fold and assemble BamA, but rely on the substrate 
remaining in an unfolded, unaggregated folding-competent state. Unlike OmpT, BamA does not 
require a chaperone to fold in vitro, but incubation of BamA with the periplasmic chaperone SurA 
or with urea is able to keep BamA in a folding-competent state. Likewise, increased 

















2.4: The Bam complex assembles OmpA in vitro 
The result that BamA does not require a molecular chaperone for its assembly in the in vitro 
reconstitution led us to believe that the periplasmic POTRA domains of BamA could play a role 
in the protein’s assembly. OMPs are secreted into the periplasm from their N- to C-termini, which 
would could allow the POTRA domains of BamA, which are at the protein’s N-terminus, to fold 
independently as they enter the intermembrane space. We hypothesized that a large soluble 
domain on BamA or other OMPs could act to shield hydrophobic regions of the OMP from the 
aqueous periplasm and keep the protein in a folding-competent state. Having reconstituted the 
assembly of OmpT and BamA, we were also interested in how generalizable the in vitro 
Figure 2.2. The Bam complex assembles BamA in vitro A. A schematic 
overview of the experimental design. Unfolded FLAG-tagged substrate is fed to 
Bam complexes, which are situated in phospholipid liposomes. B. An α-FLAG 
blot. Urea and SurA equally maintain the folding competency of BamA, while 
TBS does not. C. Bam subcomplexes lacking Bam lipoproteins are able to 
incorporate BamA into proteoliposomes. (U, unfolded FLAG-BamA; F, folded 
FLAG-BamA). Figure from ref. 23. 
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reconstitution was to the assembly of other OMPs. There were several types of OMPs to consider: 
1) those with and without soluble periplasmic domains; 2) multimeric OMPs, which frequently 
assemble into trimers in the membrane and could be expected to have different requirements for 
proper folding and insertion into the OM; and 3) LptDE, which due to its large size and the 
presence of LptE inside LptD’s β-barrel could require a higher degree of Bam protein 
coordination. Likewise, LptD and BamA are the only essential OMPs, so LptD’s assembly 
pathway is of particular interest.  
 
Two trimetric OMPs, LamB and OmpF, were screened for in vitro assembly, but no folding was 
observed. This could be due to special requirements of periplasmic components that were not 
present in the reconstitution or perhaps the high curvature of liposomes, which could interfere 
with the correct assembly of an OMP trimer.  
 
OmpA, a 35 kDa nonessential outer membrane protein whose biological function is not entirely 
known was, however, able to fold in the Bam reconstitution (Figure 2.3). OmpA is thought to 
play a role in maintaining the structure of the outer membrane and acts as the entry site for 
multiple bacteriophages.24 More important, it is distinguished by the presence of a large, soluble 
periplasmic domain at its C terminus 153 amino acids in length. We believed that we could use 
this substrate as a tool to investigate the result that BamA did not require a chaperone for its in 
vitro assembly. 
 
Two variants of OmpA were created: an N-terminally FLAG-tagged full length form of the 
protein and an N-terminally FLAG-tagged truncated form of OmpA lacking its C-terminal 
periplasmic domain (FLAG-OmpA(23-193)), a construct that consists solely of the protein’s β-
barrel domain. Both constructs were created without signal sequences and were therefore 
expressed as inclusion bodies in the cytoplasm of E. coli. The inclusion bodies were purified and 
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dissolved in 8 M urea. β-barrels are able to refold in detergent solutions, which we used as a 
positive control for folding in reconstitution experiments. For wild-type OmpA, refolding in 
detergent produced several unexpected bands at 70 and 22 kDa, which may represent a 
nonbiologically relevant dimeric form of the protein and an alternative, more compact folded 
form of OmpA, respectively. Boiling of the refolding reactions fully denatured OmpA and 
showed that the folded form of OmpA runs at the apparent molecular weight of 25 kDa and the 
unfolded form runs at 35 kDa. In the case of the truncated form of OmpA, the folded form runs at 
a higher apparent molecular weight than its unfolded form. For experiments involving liposomes, 
urea-denatured OmpA was added to Bam complex proteoliposomes directly from 8 M urea or 
was preincubated with TBS pH 8.0 or the periplasmic chaperone proteins Skp, SurA, or FkpA. 
After sixty minutes, SDS sample buffer was added to the reactions to quench any folding, the 
samples were run on semi-native SDS-PAGE, and immunoblotting with α-FLAG was used to 
















These results suggest that when it was preincubated with TBS, enough FLAG-OmpA stayed 
folding-competent to give rise to a folded band. A similar effect was seen when the substrate was 
preincubated with SurA. When preincubated with Skp or FkpA, this effect is not seen. This could 
be due to the chaperone binding too tightly to the substrate, unable to release it to the Bam 
complex, or the chaperones could somehow be promoting the aggregation of substrate during the 
preincubation. When the same experiments were done with FLAG-OmpA(23-193), the β-barrel 
construct of OmpA, we obtained similar results: this construct was folded by the Bam complex 
with TBS and SurA preincubations, but not when preincubated with Skp or FkpA. Importantly, 
we observed one striking difference between Bam-mediated folding of the two OmpA constructs. 
B
A 
Figure 2.3. The Bam complex refolds OmpA and OmpA lacking its soluble 
domain in vitro A. Wild-type OmpA refolds directly from urea and when 
preincubated with SurA or TBS, but not when preincubated with Skp or FkpA. 
B. The OmpA β-barrel domain refolds in vitro under the same conditions that 









When the truncated form of the protein is preincubated with SurA, the substrate folded 
quantitatively, while there was no significant increase in the amount of folding of the wild-type 
substrate upon preincubation with SurA versus TBS. These observations supported our initial 
hypothesis that OMPs with large soluble domains have different chaperone requirements than 
OMPs without periplasmic domains. Deletion of the soluble domain of OmpA led to a folding 
reaction that was dramatically improved by the addition of chaperones. 
 
2.5: Chaperones assist in the assembly of OmpA on Bam subcomplexes 
Based on the result of truncated OmpA folding more readily after a preincubation with SurA, we 
wondered if these effects translated to its folding on different Bam subcomplexes. Truncated 
OmpA was added from 8 M urea to different Bam subcomplexes or it was preincubated with a 
10-fold molar excess of SurA prior to its introduction to the Bam subcomplexes. Reactions were 
quenched at 60 minutes (Figure 2.4). As before, some folding of the substrate was observed when 
it was subjected to the proteoliposomes straight from urea. However, when the substrate was 
preincubated with SurA, we saw a marked difference in the amount of substrate that gets folded. 
Whenever BamA was present in the proteoliposomes, SurA greatly increased the amount of 
substrate that gets folded. The starkest increase in folding occurred in those reactions in which 
BamAB was present in the proteoliposomes. This result was surprising, as we expected the 
highest conversion of unfolded to folded OmpA by wild-type BamABCDE proteoliposomes, as 
had been seen in OmpT and BamA folding reconstitutions. These results suggest that BamC, 
BamD, and BamE may interfere with the delivery of the OmpA substrate when it is bound to 
SurA. There is evidence from crosslinking studies that BamA interacts with SurA. 5 Thus, we 
hypothesize that when BamCDE is removed from the complex, a SurA-bound substrate can more 









To understand how the folding of wild-type OmpA and the β-barrel of OmpA (OmpA(23-193)) 
proceeds over time, we conducted timecourse experiments using the in vitro reconstitution 
(Figure 2.5). The two substrates were either preincubated with SurA or pipetted from 8 M urea 
into empty liposomes or liposomes containing the full BamABCDE complex.  A single tube was 
used for each timecourse (i.e. aliquots were removed from the same reaction mixture at different 
timepoints) and aliquots were quenched at the desired time points. All samples were run on semi-
native SDS-PAGE and analyzed as described above. As expected, we observed no folding of 
OmpA or the β-barrel domain of OmpA when the folding reactions were performed in the 
presence of empty phospholipid liposomes. 
 
 
Figure 2.4. The presence of BamA in a proteoliposomes is required for the 
folding of OmpA’s β-barrel domain. Preincubation of OmpA(23-193) with the 
molecular chaperone SurA drastically increases the extent of refolding in vitro. 













As expected based on the results that we obtained in the 60 minute folding reactions (Figures 2.3 
and 2.4), wild-type OmpA accumulated over time, but the rate of folding was not significantly 
increased when the substrate was preincubated with SurA. The first detectable folded material 
appeared at the 30 minute timepoint independent of OmpA’s preincubation with SurA. 
Conversely, preincubating the β-barrel domain of OmpA with SurA significantly increased the 
substrate’s rate of folding. Like wild-type OmpA, folded β-barrel domain of OmpA was 
detectable after 30 minutes had elapsed. However, when preincubated with SurA, the folded β-
A 
B 
Figure 2.5. The Bam complex assembles the β-barrel domain of OmpA faster 
than wild-type OmpA A. Wild-type OmpA is folded by the Bam complex 
slightly faster following an incubation with SurA compared to no incubation 
with the chaperone. B. The β-barrel domain of OmpA assembles significantly 
faster and to a greater extent than wild-type OmpA when it is preincubated with 







barrel of OmpA was detected after only five minutes of incubation with the Bam complex. Again, 
the results with wild-type OmpA suggest a lack of dependence on SurA for proper assembly into 
membranes, supporting our initial hypothesis that a periplasmic domain can aid in the shuttling of 
an unfolded substrate to the Bam complex. The faster rate of truncated OmpA folding when 
preincubated with SurA, relative to the rate of wild-type OmpA without a SurA preincubation 
suggests that a SurA-bound substrate takes a separate pathway to the Bam complex than a 
substrate that does not rely on SurA. 
 
2.6: Conclusion 
The reconstitution of Bam activity in vitro is a remarkable biochemical tool for investigating the 
mechanism of OMP assembly. Work with the reconstitution has demonstrated that BamA is the 
minimal requirement for folding BamA and OmpA and that the presence of BamABCDE in a 
membrane drastically increases the rate of folding of OMPs compared to background rates of 
OMP self-assembly. Additionally, these experiments demonstrate that no energy source such as 
ATP is required for the successful assembly of OMPs, which are assembled in the periplasm 
where no energy source is present. Likewise, the folding of OmpA in vitro, as demonstrated in 
this chapter, suggests a role for soluble periplasmic domains in shielding hydrophobic regions of 
OMPs while they traverse the periplasm. Due to the adaptability of the in vitro assay, the 
assembly of other OMPs can be explored quite readily using this system. Additions of soluble 
periplasmic components to reaction mixtures could be used to determine if there are unidentified 
components necessary for the proper assembly of multimeric OMPs. Ultimately, the readout of 
the in vitro reconstitution is the presence or absence of a folded substrate and it is so far not 
possible to track individual assembly steps in vitro. To gain a more detailed understanding of 
OMP assembly requires a crystal structure of the complex and efforts for obtaining that structure 




2.7: Materials and Methods 
2.7.1: Materials 
Unless stated otherwise, all chemicals were obtained from Sigma Aldrich and, unless specified 
otherwise, all cultures were grown in lysogengy broth (LB) obtained from Difco, with antibiotics 
at a concentration of 50 µg/mL. Cultures were grown in Innova 44 incubators and pelleted using a 
Beckman Coulter J6-Mi floor centrifuge or a 5810 R desktop centrifuge from Eppendorf. The n-
dodecyl-β-D-maltopyranoside (DDM), n-octyl-β-D-glucopyranoside (OG), and 
lauryldimethylamine-N-oxide (LDAO) were obtained from Anatrace. Ni-NTA resin for protein 
purifications was obtained from Qiagen. Affinity chromatography was performed in Poly-Prep 
Chromatography Columns from Bio-Rad. Protein concentrations were determined using a 
Thermo Scientific NanoDrop 2000 UV/vis spectrometer. Purification of Bam complexes were 
performed on a GE AKTA Pure FPLC using a Superdex 200 10/30 GL gel filtration column. E. 
coli phospholipids for the formation of proteoliposomes were purchased from Avanti. 
Proteoliposomes and membrane fractions of lysed cells were pelleted using a Beckman Coulter 
Optima XE-90 ultracentrifuge. Homogenization of membrane pellets and inclusion bodies was 
performed using an IKA T18 basic ULTRA-TURRAX homogenizer.  
 
2.7.2: Plasmid construction 
Table 2.7.2.1 lists the plasmids that were used in these studies and table 2.7.2.2 lists the primers 
used to generate the plasmids. Restriction sites and sequence modifications are highlighted by 








Table 2.7.2.1. List of plasmids 
Name Description Construction 
pCH103 pET22b-bamA (E22-W810) 
PCR with primers: bamA(22-810)-5’ and 
bamA(22-810)-3’ and then site directed 
mutagenesis with primers: bamAstop-5’ and 
bamA-stop-3’ 
pCH128 pET22b-FLAG-bamA (A21-W810) 
Site directed mutagenesis of pCH103 with 
primers: FLAG-nsbamA-for and FLAG-ns-
bamA-rev 
pCH024 pET22b-Skp-His6 PCR with primers: Skp-Nns and Skp-CHis 
pSK046 pCDFDuet-bamC-bamD PCR with primers: bamC-N, bamC-C, bamD-N3, and bamD-C3 
pBamE-His pET22-42-bamE-His8 As described in Sklar et al.3 
pSK038 pETDuet-bamB- bamA PCR with primers: bamB-N, bamB-C, bamA-N, 
and bamA-C 
pSK257 pET28b-His6-SurA (A21-N428) PCR with primers: SurA-Nns and SurA-Ce 
pSK249 pET22b-ns-OmpA(23-346) PCR with primers: OmpA-Nns2 and OmpA-Ce2 
pDW050 pET22b-FLAG-ns-OmpA(23-346) 
Site directed mutagenesis of pSK249 with 
primers: FLAG-OmpA-N and FLAG-OmpA-C 
pDW051 pET22b-FLAG-ns-OmpA(23-193) 
Site directed mutagenesis of pDW050 with 
primers: FLAG-OmpA-trunc-N and FLAG-
OmpA-trunc-C 
 
































2.7.3: Preparation of Competent Cells 
A 5 mL overnight culture was grown of the desired strain with 50 µg/mL of the required 
antibiotic added to the culture. The following day, 1 mL of the overnight culture was used to 
inoculate 100 mL of autoclaved media supplemented with the appropriate antibiotic. This culture 
was shaken at 37 °C until OD600=0.3, at which point the culture is divided into two ice-cold 50 
mL tubes. These tubes were left on ice for 10 minutes and the cells were pelleted at 1,600 g. for 7 
minutes at 4 °C. The supernatant was discarded and the pelleted cells were resuspended in 10 mL 
ice-cold, sterile-filtered 60 mM CaCl2, 15% glycerol, 10 mM PIPES pH 7.0. The cells were spun 
down for 5 minutes at 1,100 g. at 4 °C, the supernatant discarded, and the cells were resuspended 
in 10 mL of the ice-cold CaCl2 solution from above. This suspension was kept on ice for 30 
minutes and the cells were spun down again at 1,100 g. for 5 minutes at 4 °C. The cells were 
resuspended in 2 mL of the ice-cold CaCl2 solution and then divided into 250 µL aliquots in 
ultracentrifuge tubes. These aliquots were immediately flash-frozen in liquid N2 and stored at -80 
°C. 
 
2.7.4: Overexpression and purification of BamAB-His 
100 mL 2X YT broth was autoclaved and upon cooling, carbenicillin was added to a 
concentration of 50 µg/mL. The broth was seeded with BL21(DE3) harboring pSK086 for 
overnight growth at 37 °C. 6 L of culture was seeded with the overnight culture and shaken at 30 
°C until OD600=0.2.  The temperature of the incubator was shifted to 25 °C and the culture was 
grown to OD600=0.6, at which protein expression was induced using IPTG at a concentration of 
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0.1 mM. The culture was grown for another 3-4 hours, at which point the cells were pelleted for 
10 minutes at 5,250 g. at 4 °C.  Cell pellets were flash-frozen in liquid N2 and stored overnight at 
-80 °C. The following morning, the cell pellet was resuspended in 60 mL 20 mM Tris pH 8.0, 50 
µg/mL DNase, 50 µg/mL RNase, 1 mM PMSF, on ice. This suspension was left on ice for 20 
minutes and then the cells were disrupted through 3 passes through a cell disrupter at 15,000 psi. 
The lysate was centrifuged at 5,250 g. for 10 minutes at 4 °C to pellet whole cells. The 
supernatant of this spin was collected and ultracentrifuged at 100,000 g. for 30 minutes at 4 °C in 
a 45 Ti rotor. The supernatant of this spin was discarded and the membrane pellet was 
resuspended in 14 mL TBS pH 8.0, 2% TX-100, 10 mM EDTA, 0.1 mg/mL lysozyme, which 
was incubated on a rocker at room temperature for 20 minutes. This solution was once more 
ultracentrifuged for 30 minutes at 100,000 g. at 4 °C to pellet any undissolved membrane 
fractions. The supernatant from this spin was collected and dialyzed overnight against 3.5 L TBS 
pH 8.0, 0.5% Triton X-100. 5 mL of Ni-NTA resin slurry was applied to a disposable plastic 
column and washed 2X with 25 mL wash buffer (TBS pH 8.0, 0.05% DDM, 40 mM imidazole). 
The dialyzed BamAB-His solution was applied to the column and the flow-through was sent 
through the column two more times to maximize protein binding to the resin. The resin was 
washed 2X with 25 mL wash buffer and the protein was eluted from the resin using 15 mL TBS 
pH 8.0, 0.05% DDM, 200 mM imidazole. The eluate was concentrated to ~10 mg/mL in a 100 
kDa molecular weight cut-off filter at 3,000 g. The BamAB-His was further purified by passing it 
through a Superdex 200 10/30 GL column on the FPLC. An isocratic elution using TBS pH 8.0, 
0.05% DDM, 1 mM TCEP was used to elute the protein and the eluate was concentrated to a 
desired concentration in a 100 kDa molecular weight cut-off filter. 
 
2.7.5: Overexpression and purification of FLAG-ns-BamA 
A 15 mL culture of a BL21(DE3) strain containing pCH128 was grown overnight at 37 °C and 
used to seed a 1.5 L culture the following morning. This culture was shaken at 37 °C until 
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OD600=0.75, at which point protein expression was induced using IPTG at a final concentration of 
100 µM. The culture was grown for an additional 4-5 hours, at which point the cells were pelleted 
at 5,250 g. at 4 °C for 10 minutes. The cells were resuspended in 25 mL TBS pH 8.0 with 1 mM 
TCEP and the cells were lysed by 3 passes through a cell disrupter at 15,000 psi. Inclusion bodies 
were pelleted at 5,000 g. at 4 °C for 10 minutes, the supernatant was discarded, and 10 mL 8 M 
urea was added to dissolve the inclusion bodies. The inclusion bodies were broken up using a 
homogenizer, then rocked at room temperature for 15 minutes to dissolve the inclusion bodies 
fully. Any undissolved material or impurities were pelleted at 6,000 g. for 10 minutes at 4 °C. 
The supernatant was collected and diluted into 45 mL TBS pH 8.0, 0.5% LDAO, and nutated 
overnight at 4 °C to refold the protein. This solution was concentrated in a 50 kDa molecular 
weight cut-off filter the following morning to ~5 mL and injected onto the FPLC using a 
Superdex 200 column, using 5 1 mL isocratic runs with TBS pH 8.0, 0.03% DDM, 1 mM TCEP 
as the running buffer. Two overlapping peaks were observed and the fractions corresponding to 
the second peak were collected and concentrated in a 50 kDa molecular weight cut-off filter to 
approximately 1 mL. This solution was passed through the Superdex 200 column on the FPLC a 
second time to purify ns-BamA or its variant further. The fractions corresponding to the folded 
protein were collected and concentrated to the desired concentration in a 50 kDa molecular 
weight cut-off filter.  
 
2.7.6: Overexpression and purification of BamCDE-His 
Two 15 mL cultures of BL21(DE3) harboring pSK086 and pBamE-His were grown overnight at 
37 °C. The following morning, each 15 mL culture was used to inoculate 1.5 LB in a 4 L flask 
and grown at 37 °C to OD600=0.7. Protein expression was induced with 100 µM final 
concentration IPTG and grown for an additional 4 to 5 hours. Cells were pelleted at 5,250 g at 
4°C for 10 min., then resuspended in 40 mL TBS pH 8.0 with 1 mM final conc. PMSF, 50 ug/mL 
Dnase, 100 ug/mL lysozyme, and 50 µg/mL RNAse. Cells were disrupted by passing this 
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suspension three times through a cell disruptor at 15,000 psi. Whole cells and inclusion bodies 
were pelleted at 5,000 g at 4 °C for 10 minutes. The pellet was discarded and the supernatant 
containing membrane fragments was ultracentrifuged in a 45 Ti rotor at 100,000 G at 4 °C for 30 
minutes. The supernatant was discarded and the brown membrane pellet was resuspended in 10 
mL TBS pH 8.0 with 2% Triton X-100, 10 mM EDTA, 0.1 mg/mL lysozyme. A homogenizer at 
power 3 was used to aid in the resuspension of the pellet. Any undissolved pieces of membrane 
were pelleted at 100,000 g at 4 °C for 30 minutes in the 45 Ti rotor. The supernatant containing 
dissolved BamCDE was collected and dialyzed overnight at 4 °C in 3.5 L TBS pH 8.0 with 0.5% 
Triton X-100. This dialysis step is to remove EDTA from the solution. The concentration of the 
dialyzed BamCDE solution was assessed, using dialysis buffer as a blank. 
 
2.7.7: Reconstruction of BamABCDE-His for biochemical experiments 
Purified BamAB (see 2.7.4) was mixed with purified, dialyzed BamCDE-His (see 2.7.6) in a 1:25 
BamCDE-His:BamAB volume ratio. 10 mL Ni-NTA resin slurry was applied to Poly-Prep 
column and washed with 2X 25 mL wash buffer (TBS pH 8.0, 0.05% n-dodecyl-β-D-
maltopyranoside, 40 mM imidazole). The  BamABCDE-His mixture was passed through the resin 
three times. The resin was washed with 2X 30 mL wash buffer and the protein complex was 
eluted using 15 mL TBS pH 8.0, 0.05% n-dodecyl-β-D-maltopyranoside, 200 mM imidazole. The 
same volume of BamCDE-His that was added to BamAB in the first step of this protocol was 
added to the flow-through from the Ni-NTA purification to create more BamABCDE-His 
complex for purification. A second Poly-Prep column was prepared as described above and the 
same purification protocol was followed to accumulate more of the protein complex. Eluates from 
the two column runs were kept separate. The eluates were concentrated to approximately 500 µL 
in 100 kDa molecular weight cut-off filters at 3,000 g. at 4 °C. This was applied to a Superdex 
200 column and eluted using an isocratic run of TBS pH 8.0, 0.03% n-dodecyl-β-D-
maltopyranoside, 1 mM TCEP at a flow rate of 0.5 mL/min. Fractions corresponding to the main 
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peak, at roughly 11 minutes, were collected and concentrated in a 100 kDa molecular weight cut-
off filter. 
 
2.7.8: Reconstruction of BamACDE-His for biochemical experiments 
Purified, dialyzed BamCDE-His was added to purified, refolded ns-BamA in a 10:1 molar ratio. 
10 mL of Ni-NTA resin slurry was applied to a chromatography column and equilibrated with 2X 
25 mL wash buffer (TBS pH 8.0, 1% n-octyl-β-D-glucopyranoside (OG), 20 mM imidazole). The 
BamACDE-His mixture was passed through the resin three times and the resin was washed with 
2X 30 mL wash buffer. The Bam complex was eluted with 15 mL TBS pH 8.0, 1% OG, 200 mM 
imidazole. Eluate was concentrated to about 10 mg/mL in a 100 kDa molecular weight cut-off 
filter and passed isocratically through a Superdex 200 column on an FPLC using TBS pH 8.0, 1% 
OG, 1 mM TCEP as the running buffer and a flow rate of 0.5 mL/min. Fractions corresponding to 
the central, main peak at roughly 11 minutes were collected and concentrated in a 100 kDa 
molecular weight cut-off filter to the desired concentration. 
 
2.7.9: Preparation of Bam complex proteoliposomes 
To form Bam complex proteoliposomes, 40 µL of a 20 mg/mL sonicated aqueous solution of E. 
coli phospholipids was added to 200 µL of a 10 µM solution of protein complex in TBS pH 8.0, 
0.03% DDM, and 1 mM TCEP. This solution was incubated on ice for five minutes, then diluted 
with 8 mL TBS pH 8.0, which reduces the DDM concentration below its CMC and forces the 
Bam proteins into phospholipid vesicles. This solution was incubated on ice for 30 minutes, at 
which point it was ultracentrifuged for 2 hours at 300,000 g. at 4 °C. The supernatant was 
discarded and the pelleted proteoliposomes were resuspended in 200 µL TBS pH 8.0, using gel-
loading tips to pipette the proteoliposome suspension up and down. Any proteoliposomes that 




2.7.10: In vitro reconstitution of OMP folding 
2.5 µL of Bam complex proteoliposomes at a concentration of 10 µM was added to 6.5 µL TBS 
pH 8.0 in a PCR tube. If no preincubation with a chaperone was desired, 1 µL of outer membrane 
protein substrate, dissolved in 8 M urea and at a concentration of 0.5 µM, was added to the tube. 
If a preincubation with a chaperone was desired, 1 µL of the outer membrane protein substrate at 
a concentration of 5 µM in 8 M urea was added to 9 µL of the chaperone in TBS pH 8.0 at a 
concentration of 50 µM. This was incubated at room temperature for 10 minutes, at which point 1 
µL of this mixture was added to a PCR tube containing 2.5 µL of Bam complex proteoliposomes 
at 10 µM and 6.5 µL TBS pH 8.0.  The folding reactions were allowed to proceed at room 
temperature for the desired amount of time, then quenched with 10 µL 2X SDS sample buffer. 
Reactions were run on a 4-12% gradient polyacrylamide gel at 150 V for 110 minutes at 4 °C. 
Proteins were transferred to a PVDF membrane and α-FLAG-HRP antibodies were used to 
visualize folded and unfolded substrate. 
 
2.7.11: Overexpression and purification of FLAG-OmpA 
A 5 mL overnight culture of BL21(DE3) harboring pDW050 (FLAG-ns-OmpA) or pDW051 
(FLAG-ns-OmpA(23-193)) was grown at 37 °C with 50 µg/mL and used the following morning 
to inoculate 500 mL LB media with 50 µg/mL. This culture was grown at 37 °C until OD600=0.4 
and protein expression was induced with 0.1 mM IPTG. The culture was grown for an additional 
3-4 hours. Cells were pelleted at 5,250 g. at 4 °C for 10 minutes. Cell pellets were resuspended in 
15 mL TBS pH 8.0, then lysed by three passes through a cell disrupter at 15,000 psi. Inclusion 
bodies were spun down at 5,250 g for 10 minutes at 4 °C. The supernatant was discarded and the 
pelleted inclusion bodies were dissolved in 5 mL 8 M urea, using a homogenizer to disrupt the 
pelleted inclusion bodies. The 50 mL tube containing this solution was rocked at room 
temperature for about 20 minutes until the inclusion bodies were fully dissolved. Undissolved 
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debris was pelleted at 20,000 g. for 20 minutes at 4 °C and the supernatant was collected. This 
solution was divided into 500 µL aliquots, flash-frozen in liquid N2, and stored at -80 °C. 
 
2.7.12: Refolding of OMPs in Detergent 
In the experiment in Figure 3.2A, the full-length and truncated FLAG-BamA substrates were 
prepared at a concentration of 5 μM in 8 M urea. They were then diluted ten-fold into a solution 
of TBS (pH 8), 0.5% LDAO and incubated at room temperature for one hour. The folding 
reactions were then stopped with 2% SDS sample loading buffer. One-tenth of each reaction was 
run on semi-native SDS-PAGE, and the products were detected by western blotting as described 
in the previous section. 
 
2.7.13: Overexpression and purification of His-ns-SurA 
A 5 mL overnight culture of BL21(DE3) harboring pCH024 was grown at 37 °C. This culture 
was used the following morning to seed 500 mL LB media with carbenicillin at 50 µg/mL. The 
cells were grown at 37 °C until OD600=1.0, at which point IPTG was added at a concentration of 
0.1 mM to induce protein expression. The temperature was shifted to 16 °C and the cells were 
grown overnight. Cells were pelleted the following morning at 5,000 g. for 10 minutes at 4 °C. 
Cells were resuspended in TBS pH 8.0 with 1 mM PMSF. This solution was then transferred to 
50 mL tubes and the cells were lysed by three passages through a cell disrupter at 15,000 psi. 
Unlysed cells and debris were pelleted at 5,000 g. for 10 minutes at 4 °C, the supernatant was 
collected, and membrane fractions were pelleted by ultracentrifugation at 100,000 g. for 30 
minutes at 4 °C. 10 mL of Ni-NTA resin slurry was applied to a chromatography column and 
equilibrated with 2X 25 mL TBS pH 8.0, 20 mM imidazole. The supernatant from the 
ultracentrifugation was passed through the resin twice to enhance the amount of bound protein, 
then washed with 2X 15 mL TBS pH 8.0, 20 mM imidazole. Bound protein was eluted with 5 mL 
TBS pH 8.0, 200 mM imidazole, which was then loaded into a 30 kDa molecular weight cut-off 
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filter and concentrated to roughly 500 µL at 4,000 g. at 4 °C. Protein concentration was assessed 
by UV/Vis and diluted to the appropriate concentration for biochemical experiments. 
 
2.7.14: Overexpression and purification of ns-Skp-His 
The method for the purification of His-ns-SurA was followed, with several exceptions. The 
BL21(DE3) strain harboring pSK257 was used for SurA expression, which contains a kanamycin 
resistance cassette instead of a carbenicillin resistance cassette. Because Skp is a smaller protein 
than SurA, a 10 kDa molecular weight cut-off filter was used to concentrate the eluate from Ni-
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3.1: Rationale for the crystallization of the Bam complex 
Monitoring the folding of OMPs using the in vitro reconstitution described in Chapter 2 provided 
valuable information about the requirements for folding several β-barrel substrates by Bam 
proteins. Despite the progress made using this assay, the reconstitution can provide only limited 
insight into the mechanistic details of OMP assembly. The readout of these assays is the 
observation of either a folded OMP or an unfolded OMP; the reconstitution could not provide us 
with methods to monitor folding intermediates of transmembrane β-barrels. In addition, no 
general in vivo or in vitro assays had been developed that could provide this detailed level of 
mechanistic information. Thus, to elucidate the roles of individual Bam lipoproteins and the 
BamA β-barrel depends not only on developing and executing additional clever in vitro 
experiments with Bam subcomplexes, but also on elucidating structural information about the 
Bam complex. 
 
As discussed in Chapter 1, structures of all four lipoproteins, BamBCDE, have been solved in 
their delipidated forms and a structure of BamA was published fairly recently.1-4 The structures of 
individual components of the complex, however, cannot provide structural information about the 
complex as a whole. Only by crystallizing the whole complex can several important questions be 
addressed, as biochemical experiments indicate that all five proteins are necessary for optimal 
activity. Published structures of BamA and BamA’s POTRA domains have shown that the 
POTRA domains can adopt multiple conformations, with a flexible linker between P2 and P3.5 A 
structure of the whole complex would reveal which conformation or conformations of the 
POTRA domains exists when Bam lipoproteins coordinate with BamA. Likewise, it is unknown 
how the lipoproteins orient themselves with respect to the β-barrel domain of BamA or to the 
POTRA domain of BamA, information that could be suggestive of a mechanism for OMP 
assembly. Interestingly, two conformations of the N- and C-terminal β-strands of the BamA 
barrel have been observed in crystal structures, with one structure showing eight hydrogen 
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bonding interactions between the strands, the other showing only two hydrogen bonding 
interactions.6 These different structures of the β-barrel support a model of β-barrel assembly 
involving a lateral gate in the β-barrel of BamA, where weakened interactions between the 
terminal strands of the barrel allow the passage of individual β-hairpins into the lipid environment 
of the OM. Alternatively, the terminal β-strands of the barrel may allow for β-augmentation 
between folding β-strands and the BamA β-barrel, a model in which the barrel of BamA expands 
to accommodate a substrate during its assembly. Obtaining a structure of BamA in complex with 
the Bam lipoproteins would show the state of this lateral gate when the complex is fully 
assembled. 
 
Ideally we would crystallize the entire BamABCDE complex, which would provide the clearest 
picture of how the complex assembles its substrates. At the same time, we were interested in 
crystallizing BamAD, the two essential components of the complex that are known to bind to one 
another through POTRA domain P5 of BamA.7 For several reasons, we decided to focus our 
efforts on the crystallization of the BamACDE complex. First, this four-protein complex contains 
the two essential components of Bam, BamA and BamD. Second, the overexpression and 
purification of this complex was well developed and this isolated complex had been shown to be 
active in vitro.8 Third, we decided to omit BamB from this targeted complex because BamB 
requires POTRA domains P2-5 of BamA to be present for BamA and BamB to copurify, which 
would have limited the number of BamA POTRA domain constructs that we would have been 
able to use in screening efforts. Fourth, the purification of BamABCDE requires purifying 
BamAB from the outer membrane, which yields considerably less BamA than its purification and 
refolding from inclusion bodies. Fifth, the BamACDE complex is stable in multiple detergents, 





3.2: Optimization of the purification of the Bam complex 
The purification of the Bam complex reported in Chapter 2 used for biochemical experiments 
served as a good starting point for crystallization experiments. When BamABCDE, BamACDE, 
or BamAB are purified by refolding BamA and reconstructing the complex by the addition of 
Bam lipoproteins, the complex shows considerable activity in vitro. This implies that at least 
some of the purified proteins are in a physiologically relevant conformation.  
 
Initial screening for crystallization conditions by Christine Hagan and Suguru Okuda produced 
several interesting crystallization conditions, one of which became a focus of the studies 
presented in this chapter. Although their method of purification gave crystal-forming protein, 
those crystals were not reproducible. We believed that this was due to some impurities in the 
purified proteins: 1) the refolding of BamA reported in Chapter 2 results in about 40% of the 
protein remaining in the unfolded state, which does not successfully separate from the folded 
form by gel-filtration and 2) a BamC degradation product predominates in the final preps of a 




















3.2.1: Separation of folded from unfolded BamA 
At the outset of this project, we were interested in developing methods for increasing not only the 
purity of folded BamA, but also the amount of BamA that could be obtained by refolding BamA 
inclusion bodies in vitro. Because the folded and unfolded forms of the protein are similar in size, 
Figure 3.1. Impurities in preparations of BamA and the BamACDE complex. 
A. When BamA is refolded in vitro and purified by size-exclusion 
chromatography, the folded and unfolded forms coelute (above). None of the 
fractions contain pure folded BamA. When fractions predominated by folded 
BamA are concentrated, approximately 40% of the protein stays unfolded. Heat 
denatures folded BamA.  B. Purified BamACDE complex contains faint band at 
34 kDa that was identified as full-length BamC (highlighted with red arrow). A 
degradation product of BamC predominates at 32 kDa. Note: this figure is of a 
BamACDE purification after optimizing the separation of folded from unfolded 
BamA. (U, unfolded BamA; F, folded BamA) All data are from semi-native 
SDS-PAGE on 4-12% polyacrylamide gels. 
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it was not possible to separate them reliably by size-exclusion chromatography—other methods 
had to be devised.  
 
Several methods exist for refolding inclusion bodies, including diluting the unfolded protein 
directly into refolding buffer, dialyzing the unfolded protein against a refolding buffer, and 
diluting the chemical denaturant against a refolding buffer on a microfluidics chip.9 The method 
for refolding BamA that is reported in Chapter 2 relies on slow dilution of urea-denatured BamA 
inclusion bodies into a refolding buffer containing lauryldimethylamine-N-oxide (LDAO), which 
is incubated overnight at 4 °C. Because this method produced biochemically active BamA, we 
opted to optimize this method instead of pursuing alternative refolding methods. We began by 
screening for conditions to increase the amount of folded BamA observed after nutating at room 
temperature in refolding buffer for 12-16 hours. We hypothesized that refolding BamA at a 
greater temperature than 4 °C would drive BamA to adopt its thermodynamically more favorable, 
folded state. Detergents including n-dodecyl-β-D-maltopyranoside (DDM) and n-octyl-β-D-
glucopyranoside (OG) were screened and we chemical additives including 500 mM arginine and 
400 mM glycerol—reported to improve the refolding of lysozyme and other proteins in vitro—
were also screened.10-12 Lastly, we examined the effects of coincubation of unfolded BamA with 
refolding buffer containing BamCDE or SurA. We hypothesized that the Bam lipoproteins or a 
periplasmic chaperone may be able to coordinate with periplasmic loops or the periplasmic face 
of BamA’s β-barrel to assist its refolding. Refolding BamA at room temperature in LDAO 
increased the proportion of folded material, but none of the other conditions improved the 
efficiency of BamA refolding. 
 
Next, we screened conditions to improve the separation of folded BamA from unfolded BamA 
during size-exclusion chromatography. The method reported in Chapter 2 results in a crude 
separation of unfolded from folded BamA, with TBS pH 8.0, 0.03% DDM, and 1 mM TCEP as 
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the running buffer (Figure 3.1. A). We screened conditions that we hypothesized could fold 
additional amounts of BamA on the column, thereby enriching the eluate with the folded form. 
These conditions included increasing the concentration of DDM in the running buffer, increasing 
the concentration of NaCl in the running buffer, lowering the concentration of refolded BamA 
injected onto the column, and co-injected periplasmic chaperones with the refolded BamA. We 
believed that a higher salt concentration could lead to increased folding by driving hydrophobic 
regions of unfolded BamA into detergent micelles and that a lower concentration of BamA 
injected onto the column would increase the resolution of peaks as they came off of the column. 
Finally, since protein chaperones such as SurA keep unfolded OMPs folding-competent in the 
periplasm, we hypothesized that co-injection of SurA with the refolded BamA could aid in its on-
column refolding. Unfortunately, none of these conditions improved the separation of unfolded 
BamA from its folded form. 
 
The folded and unfolded forms of BamA run at apparent molecular weights of ~60 kDa and ~85 
kDa, respectively. It is not surprising that these two proteins do not separate well by size-
exclusion in a Superdex 200 column. We believed that we could exploit other differences in the 
physical properties of the two forms of BamA to segregate them more effectively. Namely, we 
believed that the folded and unfolded forms would present different amounts of charged or polar 
residues to their aqueous surroundings and that this physical difference would be present 
independent of the protein’s location in a detergent micelle. Thus, we explored anion-exchange 
chromatographic methods to exploit these physical differences. We used a MonoQ 5/50 GL 
column from GE Life Sciences, which is packed with beads covalently linked to a positively-
charged quaternary amine to screen for methods of separating the two species.  
 
Anion exchange relies on a negatively-charged protein binding to the positively charged resin, 
which is then eluted using a high concentration of salt. If there are anionic small molecules 
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present in the running buffer, they compete with the protein for binding onto the resin. If they 
bind tightly enough, they may not elute and will clog the column. For this reason, the LDAO used 
to refold BamA in vitro had to be replaced with a nonionic detergent. Fortunately, we had found 
that DDM was able to refold BamA, albeit to a lesser extent than LDAO. Screening of detergent 
concentrations, salt concentrations, various buffers, and gradients between the running buffer and 
the elution buffer resulted in a reliable way to separate folded BamA from its unfolded form that 
does not require any size-exclusion steps (Figure 3.2). BamA is expressed without its signal 
sequence, the inclusion bodies are purified, dissolved in urea, then added drop-wise to a solution 
of TBS pH 8.0 and 0.25% DDM in a 1:9 v/v ratio. The refolded material is concentrated the 
following morning and injected onto a MonoQ column with 20 mM bis-tris pH 6.5, 1% OG as the 
running buffer and 20 mM bis-tris pH 6.5, 1% OG, 1 mM TCEP, 1 M NaCl as the elution buffer. 
The pI of BamA is roughly 5.1, so a pH 6.5 buffer was used to keep BamA negatively charged 
and to exacerbate any charge differences between the folded and unfolded forms of BamA 
without neutralizing the protein and causing it to aggregate. Likewise, the micelle weight of OG 
is approximately 17 kDa, which we hypothesized was small enough to expose the maximal 
amount of charged BamA moieties to the anion-exchange resin for increased differentiation 












3.2.2:  Purification of POTRA domain truncations of BamA 
Our crystallization efforts focused on the BamACDE subcomplex, which provides more 
flexibility for creating POTRA domain truncations of BamA. Were BamB to be included in the 
complex, POTRA domains 2-5 would have to be retained for the BamACDE complex to bind to 
BamB. BamCDE, on the other hand, only requires P5 to bind to BamA and it is through BamD 
that BamC and BamE coordinate with BamA.5 To expand the search space for crystallization 
conditions, we investigated the generalizability of the refolding and anion-exchange purification 
methods to POTRA domain truncations of BamA. 
 
An unfolded OMP quickly aggregates in an aqueous environment, which is why macromolecular 
periplasmic chaperones that sequester hydrophobic regions of OMPs from water in the periplasm 
are necessary for the trafficking of OMPs to the OM.13,14 We found that BamA constructs lacking 
POTRA domains were less soluble than full-length BamA in refolding buffer and that the 
refolding solution became increasingly viscous when fewer POTRA domains were present on 
BamA. Because the POTRA domains are soluble and the results presented in Chapter 2 show that 
soluble periplasmic domains of OMPs may act as chaperones, these observations did not surprise 
us.15 Nevertheless, the insolubility of some of these constructs made purification more difficult, if 
B 
Figure 3.2. Folded BamA is able to be separated from its unfolded form by 
anion-exchange chromatography A. An anion-exchange chromatogram using 
the method described in 3.6.3. The large central peak is folded BamA. B. Semi-
native SDS-PAGE of anion-exchange fractions. 
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not impossible, using the method described above. We were able to purify BamAΔP1, 
BamAΔP1-2, and BamAΔP1-3 successfully, but not BamAΔP1-4 (Figure 3.3). 
 
 
Figure 3.3. (continues on next page). A. Anion-exchange chromatogram of 
BamAΔP1 and B. the collected fractions run on semi-native SDS-PAGE. 
Folded protein runs at a lower apparent molecular weight than the unfolded 
form. C. Anion-exchange chromatogram of BamAΔP1-2 and D. a semi-native 
SDS-PAGE of the collected fractions. E. Anion-exchange chromatogram of 














3.2.3: Purification of BamACDE 
With pure folded BamA and POTRA domain truncations of BamA in hand, we reconstructed the 
BamACDE, BamAΔP1CDE, BamAΔP1-2CDE, and BamAΔP1-3CDE subcomplexes in vitro, 
which is described more fully in 3.6.5. Briefly, folded BamA is mixed with BamCDE in a 10:1 
molar ratio. BamCDE are purified from a single strain and past work had established that this 
method resulted in a 1:1:1 mixture of the lipoproteins.8 Additionally, a polyhistidine tag on 
BamE is used to pull down the complex, so an excess of folded BamA was used to maximize the 
amount of BamACDE in the final purification. This mixture was applied to Ni-NTA resin, 
washed, and eluted. A final pass through a Superdex 200 size-exclusion column was used to 
remove any impurities from the nickel column eluate and to eliminate imidazole from the buffer. 
During the washing and elution steps of the nickel column, the OG and Triton X-100 present in 
the BamACDE mixture was exchanged with the detergent desired for final crystallization 
screening. Likewise, the running buffer for size-exclusion chromatography contained the 
detergent that was desired for crystallization screening. Following elution from the size-exclusion 
column, peak fractions were collected and concentrated for crystallization. A representative semi-
native SDS-PAGE analysis of nickel column fractions and concentrated BamACDE eluate from 











We screened multiple detergents to determine how stable the BamACDE complex is in varying 
chemical environments. In total, eight detergents were screened: n-octyl-β-D-glucopyranoside, n-
nonyl-β-D-glucopyranoside, n-dodecyl-β-D-maltopyranoside, n-decyl-β-D-maltopyranoside, 
tetraethylene glycol monooctyl ether (C8E4), dimethyldecylphosphine oxide (APO-10), CYMAL 
5, and CYMAL 6. With the exception of C8E4, the results of which are discussed in the 
conclusion of this chapter, and DDM, which produced two very closely overlapping peaks by 
size-exclusion chromatography, the screened detergents did not dissociate lipoproteins from 
BamA or BamA with truncated POTRA domains and the whole complex eluted in one 
monodisperse peak (Figure 3.5). 
Figure 3.4. Semi-native SDS-PAGE of the purification steps of BamACDE in 
n-octyl-β-D-glucopyranoside. The four proteins co-elute and show a 1:1:1:1 ratio 



















Figure 3.5. BamACDE purifications in various detergents. (OG, n-octyl-β-D-
glucopyranoside; NG, n-nonyl-β-D-glucopyranoside; DM, n-decyl-β-D-
maltopyranoside; DDM, n-dodecyl-β-D-maltopyranoside, APO-10, 
dimethyldecylphosphine oxide; C8E4, tetraethylene glycol monooctyl ether.) 
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3.3: Screening of BamACDE crystallization conditions 
Although a small amount of full-length BamC remained in preparations of BamACDE and 
POTRA domain truncations of BamA in complex with BamCDE, early crystal screening 
produced several promising conditions. Similarly, the condition that Christine Hagan and Suguru 
Okuda had found became reproducible with the new, purer folded BamA (Entry 1 in Table 3.1). 
Crystallization conditions were screened extensively using full-length BamA, BamAΔP1, 
BamAΔP1-2, and BamAΔP1-3 in complex with BamCDE, which were purified in the seven 
detergents that did not dissociate the complex (Figure 3.5). Crystallization temperature and the 
ratio between the volume of protein and the volume of reservoir solution added to each drop were 
two additional variables that were manipulated during initial screening efforts. Finally, we 
methylated the lysines of the Bam complex according to the protocol described by Walter et al.16 
This technique has been reported to improve crystal contacts in some crystallized proteins by 
reducing the pI of the crystallized protein. Approximately 20,000 conditions were screened using 
commercially available block screens MemGold, MemGold 2, ProComplex, ProPlex, MbClass I 
& II, PEGs I & II, Clear Strategy Screen I & II, Crystal Screen I & II, MemPlus, MemFac, and 
MemSys, which were purchased from Hampton Research, Molecular Dimensions, or Qiagen. 
Initial screening was performed in 96-well MRC3 plates and trays were set at 4 °C or 20 °C. The 
trays were imaged at regular intervals over the course of one month to monitor crystallization.  
 
When purified in most of the detergents listed above, the Bam complex did not form any crystals 
under screened conditions. N-octyl-β-D-glucopyranoside and n-nonyl-β-D-glucopyranoside 
produced the most number of hits, which may have been a result of their small micelle size, so 
efforts became focused on these two detergents as screening progressed. Additionally, the 
suitability of glucosides for Bam crystallization led us to screen extensively for crystallization 
using OG- or NG-purified Bam complex in dimyristoyl phosphatidylcholine (DMPC) and (3-[(3-
cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate) (CHAPSO) bicelles. 
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Bicelles can be thought of as solubilized lipid bilayer discs wherein a long-chain lipid (DMPC) 
forms a piece of a bilayer that is encased in a short-chain lipid or detergent (CHAPSO).17 When a 
protein that has been purified in a detergent is added to a bicelle solution, it incorporates into the 
lipid bilayer discs, which more closely resemble the membrane environment that a 
transmembrane protein would experience in vivo than a detergent micelle. Bicelles are also 
amenable to use with proteins purified in detergent, so adapting our purification protocols for 
bicelle crystal screening was not challenging. Finally, the published structure of BamA had been 
solved from crystals that formed from bicelles, providing evidence that we could obtain hits using 
bicelles.2 Table 3.1, below, shows a selection of hits from initial screening efforts. 
 
Table 3.1. Initial crystallization hits 
Entry Construct Detergent Crystallization Condition Crystallization Temperature 
1 BamACDE 16 mg/mL 1% OG 
100 mM trisodium citrate pH 5.6 
1 M ammonium dihydrogen phosphate 






Entry Construct Detergent Crystallization Condition Crystallization Temperature 
2 BamAΔP1-2CDE 16 mg/mL 1% OG 
100 mM tris pH 7.5 




Entry Construct Detergent Crystallization Condition Crystallization Temperature 
3 BamACDE 17 mg/mL 1% OG 
100 mM MgCl2 
100 mM tris pH 7.5 






Entry Construct Detergent Crystallization Condition Crystallization Temperature 
4 BamAΔP1CDE 15 mg/mL 1% OG 
100 mM NaCl  
30% PEG 400  




Entry Construct Detergent Crystallization Condition Crystallization Temperature 
5 BamAΔP1CDE 9.4 mg/mL 




100 mM trisodium citrate pH 5.6 













100 mM NaCl  




Entry Construct Detergent Crystallization Condition Crystallization Temperature 





100 mM sodium acetate pH 5.0 
15% MPD 






Entry Construct Detergent Crystallization Condition Crystallization Temperature 
8 BamACDE 16 mg/mL 
0.7% OG 
7% DMPC + 
CHAPSO 
bicelles 
100 mM sodium citrate pH 5.5 
200 mM KCl 





3.4: Optimization of BamACDE crystals 
Reproducing crystals grown under the conditions presented in Entries 2, 4, 5, 6, and 7 of Table 
3.1 proved difficult and none of the crystals that were irradiated diffracted to a high resolution. 
Crystals grown under the Entry 7 condition were not at all reproducible. 
 
The crystallization condition for Entry 2 was not highly reproducible, so we screened fewer 
conditions for improved crystallization. Grid screens probing the effects of pH, BamAΔP1-2CDE 
concentration, and Jeffamine concentration did not produce crystals reliably. We also tested the 
ability of BamAΔP1CDE to crystallize under the initial conditions, but it did not. Finally, we 
screened cryoprotectants 30% PEG 400, 20% ethylene glycol, various concentrations of 
Jeffamine, and the CryoOil Fomblin. At best, the crystals diffracted to ~15 Å at APS. 
 
Crystals grown under the Entry 3 condition were reproducible, which allowed for extensive 
screening for high-resolution crystals. Grid screens were constructed to examine the influence of 
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pH, the concentration of PEG 400, the concentration of BamACDE, the concentration of 
magnesium chloride, drop volume, and reservoir volume. We also screened the ratio of protein to 
reservoir in crystal drops, temperature, alternative PEGS (PEGs 200, 300, 350, 550, and 1000), 
using 2-methyl-2,4-pentanediol (MPD) as the precipitant, alternative chloride salts (CaCl2, 
MnCl2, SrCl2, CrCl2, KCl, and NaCl), and the presence of paraffin or silicon oil above the 
droplets to slow crystal growth. Finally, we tested the abilities of BamAΔP1CDE and BamAΔP1-
2CDE to crystallize under these conditions. No screen produced larger crystals or crystals with a 
different morphology than the original hit. Crystals were picked for collection of diffraction data, 
using 30% PEG 400 in mother liquor as the cryoprotectant, which was added directly to 
crystallization drops. Crystals were flash-frozen in liquid N2, sent to APS, and irradiated at 100 
K, but none of the crystals produced measurable diffraction. 
 
Crystals grown under the Entry 4 condition were somewhat reproducible, but screening across 
pH, PEG 400 concentration, drop volume, and the volume of the reservoir did not produce larger 
crystals. Of the crystals that did grow, several were cryoprotected by addition of reservoir with 
20% ethylene glycol and flash-frozen in liquid N2 for shipment to the Advanced Photon Source 
(APS) at the Argonne National Laboratory. At best, these crystals diffracted to ~20 Å. 
 
The crystallization conditions presented under Entry 5 and 6 are quite similar: both contain 
trisodium citrate at a pH similar to the pI of BamA, which is 5.1. The crystals grown under both 
of these conditions grew overnight and share similar morphologies. Due to the buffer pH of 5.0 or 
5.5, the small size of the crystals, and the fast rate at which the crystals grew, we suspected that 
the Bam complex was entering a disordered crystalline state. Nevertheless, the crystals were 
reproducible, which allowed us to screen across pH, concentrations of PEG 400, concentrations 
of BamAΔP1CDE (Entry 5) and BamAΔP1-2CDE (Entry 6), temperature, reservoir volume, drop 
size, and larger PEGs as precipitants. Crystals were cryoprotected by serial transfer into mother 
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liquor containing either 30% PEG 400, MPD, or the CryoOils Foblin Y and Krytox. When 
irradiated at APS, crystals diffracted to ~20 Å. 
 
3.4.1: Optimizing BamACDE crystals grown in ammonium dihydrogen phosphate 
Entry 1 in Table 3.1, the condition that our lab had discovered prior to the work reported here, 
had only produced several crystals when the purified BamACDE complex contained 
contaminating, unfolded BamA. Several of these early crystals were cryoprotected using mother 
liquor with 20% ethylene glycol and screened for diffraction at APS. Crystals diffracted only to 
~12 Å, but enough data were collected to place the crystals into the P6122 space group with unit 
cell dimension a = b = 111.2 Å, c = 755.9 Å with a solvent content of ~70%, as determined by 
Matthews coefficient. Upon crystallizing BamACDE under this condition with a preparation 
lacking unfolded BamA, the crystals were robustly reproducible and therefore amenable to 
extensive optimization screening. 
 
Potential improvements were screened by examining the effects of pH, BamACDE concentration, 
ammonium dihydrogen phosphate concentration, drop volume, reservoir volume, the ratio of 
protein to reservoir volume, temperature, the addition of E. coli phospholipids to the purified 
complex, purification of the complex in n-nonyl-β-D-glucopyranoside, as well as additive 
screening using the Hampton Research 96-well additive screen, the MemAdvantage screen from 
Molecular Dimensions, the Detergent Screen HT from Hampton Research, and the Silver Bullets 
additive screen from Hampton Research. No additive screen or adjustment to the crystallization 
condition resulted in crystals with a new morphology. Likewise, when BamACDE was purified in 
NG and set in trays under the crystallization conditions, no crystals formed. The same was true 
when BamA POTRA domains truncations in complex with BamCDE were set in the base 
crystallization condition. Screening for diffraction of crystals at APS led us to a slightly modified 
crystallization condition that produced fewer, larger crystals of the complex. This crystallization 
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condition was 100 mM trisodium citrate pH 6.4, 800 mM ammonium dihydrogen phosphate, 50 
mM sodium fluoride. We also screened cryoprotectants PEG 400, ethylene glycol, glycerol, 
diethylene glycol, xylitol, glucose, NH4H2PO4, and a high concentration of trisodium citrate. 20% 
ethylene glycol produced crystals that froze clear and that diffracted to the highest resolution 
(Figure 3.6, C.). 
 
Several hundred crystals grown under this condition were irradiated at APS, all of which 
displayed a high degree of anisotropy, diffracting to ~6 Å along the z-axis of the unit cell and to 
~9 Å along the other two axes. Two representative frames and a photo of a mounted crystal are 
presented in Figure 3.6, below. The output from AIMLESS, which is software at the APS 
beamline that indexes diffraction data, is presented below in Figure 3.7. Indexing of the data in 
XDS showed that the complex packed into the P6122 space group, just as the original crystals had 
done. After scaling in XDS, the anisotropy server at UCLA was employed to correct for our 
highly anisotropic data and molecular replacement attempts were conducted using Phaser in 
Phenix.18 We used BamA, POTRA domain truncations of BamA, loop deletions of BamA, 
BamD, BamC, and the BamCD complex as search models, but no reasonable MR solutions were 
found. We suspected that this was due to the very large unit cell of these crystals, which implies 
that multiple BamACDE complexes comprise the asymmetric unit. Our search models were, 
compared to the total mass of two or more Bam complexes, very small, which may explain why 






















Figure 3.6. A. and B. Two representative frames resulting from the irradiation 
of BamACDE crystals grown in ammonium dihydrogen phosphate, trisodium 
citrate, and sodium fluoride. C. Photo of BamACDE crystal mounted on the 24-







Since phasing the data using MR did not work, we prepared a selenomethionine-labeled BamA 
for experimental phasing. BamA is the largest protein in the Bam complex and contains 14 
methionine residues. To obtain a usable signal for phasing requires one selenomethionine per 
approximately 120 amino acids and the Bam complex as a whole contains roughly 1,400 amino 
acids, so labeling BamA by itself was expected to be sufficient. SeMet-BamA was overexpressed 
and purified according to the protocol reported by Van Duyne et al. (see 3.6.7 for the complete 
method).19 The BamACDE complex was reconstructed and crystals were grown using the 
Table 3.2. Crystallographic parameters and statistics associated with crystals 
grown under the Entry 1 condition in Table 3.1. 
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conditions reported above. Nevertheless, these crystals diffracted to, at best, ~8 Å, which was not 
high enough resolution to be useful for phasing. 
 
We pursued an additional method in attempts to improve the quality of these crystals. It has been 
reported that post-crystallization dehydration of crystals can decrease the water content in a 
crystal, which can improve crystal packing and produce higher resolution data than crystals that 
had not been dehydrated.20 Briefly, crystals were removed from their drops and placed into 
mother liquor in a different well in which the concentration of ammonium dihydrogen phosphate 
was greater than 800 mM. The new well was sealed and incubated for hours to days, at which 
point the dehydrated crystal was picked and flash-frozen in liquid N2. Alternatively, the reservoir 
solution in a well was removed and replaced with a solution containing ammonium dihydrogen 
phosphate at a higher concentration than 800 mM, the well was resealed and incubated for hours 
to several days, and the dehydrated crystals were picked, cryoprotected in mother liquor 
containing 20% ethylene glycol, and flash-frozen in liquid N2. None of the crystals that we 
dehydrated diffracted to a resolution greater than ~12 Å. 
 
While the BamACDE complex had been made purer by enriching the amount of folded BamA in 
its preparation, A small amount of full-length, undegraded BamC was present in the purified 
complex (Figure 3.1). In the published structure of a BamCD complex, a large C-terminal loop 
remained disordered and its structure was unable to be determined.4 We hypothesized that 
removal of 10-25 amino acids from the C-terminus of BamC would provide a cleaner purification 
of BamACDE, removing any full-length BamC (~34 kDa) and leaving only the truncated form 
(~32 kDa) that appears in preparations of the complex. Constructs lacking 10, 15, 20, and 25 
amino acids for the C-terminus of BamC were constructed (Table 3.4) and Bam complexes 
containing these BamC constructs were purified using the same method as wild-type BamACDE 




3.4.2: Optimizing BamACDE crystals grown in pentaerythritol propoxylate 
The shower of crystals depicted in Entry 8 of Table 3.1 formed after 12 hours at 20 °C in a 2:1 
protein volume to reservoir volume drop with a total volume of 225 µL. Grid screening across 
pH, pentaerythritol propoxylate concentration, BamACDE concentration, KCl concentration, 
drop volumes, ratios of protein volume to reservoir volume, OG concentration, the use of 
pentarythritol ethoxylate as a precipitant, and additives from the 96-well Hampton Research 
additive screen gave a reliable crystallization condition that produced fewer, larger Bam complex 
crystals (Figure 3.7). The newer condition consisted of 100 mM sodium citrate pH 6.2, 35% 
pentaerythritol propoxylate, and 200 mM KCl, with the Bam complex at 15 mg/mL. Crystals 






Pentaerythritol propoxylate resembles a branched, short-chain PEG, so we believed that the 
concentration of this precipitant in the crystallization condition was sufficient to cryoprotect the 
Figure 3.7. Crystals of BamACDE grown in OG bicelles, with reservoir 
solution consisting of 100 mM sodium citrate pH 6.2, 35% pentaerythritol 
propoxylate, and 200 mM KCl. 
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crystals during flash-freezing in liquid N2. Crystals were flash-frozen directly from the drops in 
which they grew and irradiated at APS (Figure 3.8). Crystals frozen in the fashion described here 
did not freeze well and diffracted to, at best, ~12 Å. Alternative cryoprotectants such as glycerol, 
ethylene glycol, and PEG 400 caused the crystals to dissolve in their drops and any crystals that 








While the studies presented in this chapter were being conducted, several groups reported 
structures of the BamACDE complex and structures of the whole BamABCDE complex from E. 
coli (Figure 3.9).21,6,22 The expression and purification methods reported by the authors of these 
papers differ from the protocols that we had employed in several instructive ways. Their 
procedures relied on the expression of all Bam proteins in one strain of E. coli off of a single 
plasmid. Unlike our method of purification, which relied on three plasmids contained in two E. 
coli strains, the expression of all five Bam proteins in one strain almost ensures that the proteins 
are expressed in a 1:1:1:1:1 ratio. We pursued the crystallization of BamACDE that was 
reconstructed from BamA and BamCDE because it could be produced in high yield and it had 
Figure 3.8. Pentaerythritol propoxylate fails to cryoprotect BamACDE crystals 
grown in 100 mM sodium citrate pH 6.2, 35% pentaerythritol propoxylate, and 
200 mM KCl (left). A representative frame from BamACDE crystals grown 
under these conditions (right). 
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been shown to be active in vitro. Our method relied on the refolding of BamA inclusion bodies, 
which may result in several distinct folding states of BamA that could not be separated from one 
another. On the other hand, the newly reported methods purify all five Bam proteins from the 
outer membrane, where their folding state is likely homogenous and active. Along those same 
lines, the newly reported purification of the BamABCDE complex relied on C8E4 in the 
purification buffer, which we found to dissociate the BamACDE complex (Figure 3.5). Perhaps 
behavior we observed was due to multiple folding states of BamA following its in vitro refolding, 




Figure 1.4. The structure of BamABCDE viewed parallel to (A) and 
perpendicular to (B) the outer membrane. From ref. 22. pdb:5AYW 
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The crystal structure of BamABCDE shows that the POTRA domains of BamA form a bent, ring-
like structure on the periplasmic face of the complex, which coordinate the Bam lipoproteins and 
create a cylindrical chamber that may be relevant for the binding of chaperones transporting OMP 
substrates to the OM. The authors hypothesized that this ring-like structure may rearrange upon a 
chaperone-OMP complex binding to the Bam proteins, which could cause destabilization of the 
OM and facilitate the insertion of a folding β-barrel into the outer membrane.21 Additionally, the 
BamABCDE complex confirms the unusual arrangement of the N- and C-terminal β-strands of 
BamA, which demonstrate a misalignment and thus a weaker interaction than other, fully-aligned 
β-strands in the barrel. Furthermore, POTRA domains 2, 3, and 5 coordinate with the BamA β-
barrel at the junction between these terminal strands and form a 16 Å X 42 Å surface hole that 
may serve as an exit point for OMP substrates. The newly published structures of the Bam 
complex answer the questions that we had set out to answer: 1) how the POTRA domains of 
BamA are arranged with respect to the Bam lipoproteins, 2) how the Bam lipoproteins 
coordinated with respect to the β-barrel of BamA, and 3) if the conformations of the terminal β-
strands of BamA suggest a mechanism for OMP assembly. With structures of the Bam complex 
available, new, structurally-informed biochemical experiments addressing the mechanism of 
OMP assembly can be devised. Likewise, the detailed understanding of the complex’s three-











3.6: Materials and Methods 
3.6.1: Materials 
Unless specified otherwise, cultures were grown in lysogeny broth obtained from Difco, with 
necessary antibiotics at a concentration of 50 µg/mL and shaken in Innova 44 or New Brunswick 
Scientific C25KC incubators.  n-dodecyl-β-D-maltopyranoside (DDM), n-dodecyl-β-D-
maltopyranoside (DM), n-nonyl-β-D-glucopyranoside (NG), tetraethylene glycol monooctyl ether 
(C8E4), n-octyl-β-D-glucopyranoside (OG), APO-10, Cymal 5, Cymal 6, and 
lauryldimethylamine-N-oxide (LDAO) were obtained from Anatrace detergents for protein 
purification were purchased from Anatrace. MbClass I Suite, MbClass II Suite, MemGold, 
MemGold 2, MemStart, MemSys, MD ProPlex, Nextal ProComplex, Clear Strategy I, Clear 
Strategy II, MemPlus, and additive screens were obtained from Qiagen, Molecular Dimensions, 
and Hampton Research. Buffers, salts, and precipitants for crystal growth were purchased from 
Sigma-Aldrich and Hampton Research. Seeding experiments were performed with a Seed Bead 
or crystal seeding tool from Hampton Research. ALS pucks for shipping cryo-cooled crystals 
were purchased from Crystal Positioning Systems. Crystals were grown in 24-well Cryschem 
Plates or 3-well MRC3 plates from Hampton Research. 3-well trays were set using a Formulatrix 
NT8 liquid handler and stored at 4 °C or 20 °C in hotels from Formulatrix. Crystals grown in 24-
well plates were visualized using a Zeiss Discovery U8 microscope with a Plan S 1.0 X FWD 81 
mm objective. An AKTA Pure FPLC system from GE Healthcare Life Sciences was used to 
conduct size-exclusion and anion-exchange chromatography. 
 
3.6.2: Plasmid construction 
Table 3.3 lists the plasmids that were used in these studies and Table 3.4 lists the primers used to 
generate the plasmids. Any plasmids references in the following methods that do not appear in 
Table 3.3 can be found and their constructions described in Table 2.7.2.1 in Chapter 2. Restriction 
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sites and sequence modifications are highlighted by bolding. All genes were amplified from E. 
coli lab strain MC4100.  
Table 3.3: List of plasmids 
Name Description Construction 
pSK131 pET22b-bamAΔP1 PCR with primers: p2N2 and bamA-Ce 
pSK133 pET22b-bamAΔP1-3 PCR with primers: p4N2 and bamA-Ce 
pCH036 pET22b-bamAΔP1-2 
PCR with primers: p3N2 and bamA-Ce and 
then site directed mutagenesis with bamA-
G172-5’ and bamAG172-3’ 
pDW053 pCDFDuet-BamC(1-338)-BamD Site directed mutagenesis in pSK046 with primers: BamC-10aa-for and BamC-10aa-rev 
pDW054 pCDFDuet-BamC(1-333)-BamD Site directed mutagenesis in pSK046 with primers: BamC-15aa-for and BamC-15aa-rev 
pDW055 pCDFDuet-BamC(1-328)-BamD Site directed mutagenesis in pSK046 with primers: BamC-20aa-for and BamC-20aa-rev 
pDW056 pCDFDuet-BamC(1-323)-BamD Site directed mutagenesis in pSK046 with primers: BamC-25aa-for and BamC-25aa-rev 
pDW057 pET28b-BamE-His8 
Gibson assembly with empty pET28b and 
pBamE-His8 using primers: insert-amp-for, 
insert-amp-rev, vector-amp-for, and vector-
amp-rev 
 
























3.6.3: Overexpression, purification and refolding of ns-BamA and POTRA truncations of 
ns-BamA 
A 15 mL culture of BL21(DE3) harboring pCH103 (ns-BamA), pSK131 (ns-ΔP1-BamA), 
pCH036 (ns-ΔP1-2-BamA), or pSK133 (ns-ΔP1-3-BamA) was grown overnight at 37 °C in LB 
broth with 50 µg/mL carbenicillin. This culture was used to seed 1.5 L of LB with 50 µg/mL 
carbenicillin, which was grown at 37 °C to OD600=0.7. Protein expression was induced with a 
final concentration of 100 µM IPTG and the culture was allowed to grow for an additional 4 to 5 
hours. Cells were pelleted at 5,250 g. at 4 °C for 10 minutes, then resuspended in 40 mL TBS pH 
8.0 with 1 mM PMSF, 50 µg/mL DNAse, 100 µg/mL lysozyme, and 50 µg/mL RNAse. Cells 
were passed 3 times through a cell disrupter at 15,000 psi. Inclusion bodies were pelleted at 5,000 
g. at 4 °C for 10 minutes and the supernatant was discarded. The inclusion bodies were 
resuspended in 10 mL TBS pH 8.0 to wash them of debris and then repelleted at 5,000 g. at 4 °C 
for 10 minutes. The inclusion bodies were resuspended and dissolved in 5 mL 8 M urea. To 
enhance the rate of dissolution, the inclusion bodies were broken up using homogenizer. Any 
insoluble impurities were pelleted by centrifuging the urea solution for 10 minutes at 20,000 g. at 
4 °C. The supernatant was collected and diluted 10-fold into 20 mM Tris-HCl pH 8.0, 0.25% 
DDM, then nutated overnight at 4 °C to refold the inclusion bodies. This solution was 
concentrated to a volume of approximately 5 mL in a 50 kDA molecular weight cut off filter. To 
separate folded from unfolded BamA, this solution was passed through a MonoQ 5/50 GL 
column on the AKTA pure FPLC in 5 injections of 1 mL, using a 2 mL loop. The loading buffer 
for the purification consisted of 20 mM bis-tris pH 6.5, 1% octyl glucopyranoside and the elution 
buffer was composed of 20 mM bis-tris pH 6.5, 1% octyl glucopyranoside, 1 M NaCl, and 1 mM 
TCEP. At a constant flow rate of 1.3 mL per minute, each run was performed as follows: 5 mL of 
loading buffer to equilibrate the column, then 5 mL loading buffer to load the sample onto the 
column, then a 35 mL linear gradient from 0% elution buffer to 35% elution buffer, then 5 mL 
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100% elution buffer to clean the column of impurities, and then 5 mL of loading buffer to 
equilibrate the column. Fractions from the main peak were collected and the concentration was 
measured using elution buffer used as a blank. 
 
3.6.4: Overexpression and purification of BamCDE-His 
Two 15 mL cultures of BL21(DE3) harboring pSK046 and pA8H were grown overnight at 37 °C. 
The following morning, each 15 mL culture was used to inoculate 1.5 LB in a 4 L flask and 
grown at 37 °C to OD600=0.7. Protein expression was induced with 100 µM final concentration 
IPTG and grown for an additional 4 to 5 hours. Cells were pelleted at 5,250 g. at 4°C for 10 min., 
then resuspended in 40 mL TBS pH 8.0 with 1 mM final conc. PMSF, 50 ug/mL Dnase, 100 
ug/mL lysozyme, and 50 µg/mL RNAse. Cells were disrupted by passing this suspension three 
times through a cell disruptor at 15,000 psi. Whole cells and inclusion bodies were pelleted at 
5,000 G at 4 °C for 10 minutes. The pellet was discarded and the supernatant containing 
membrane fragments was ultacentrifuged in a 45 Ti rotor at 100,000 g. at 4 °C for 30 minutes. 
The supernatant was discarded and the brown membrane pellet was resuspended in 10 mL TBS 
pH 8.0 with 2% Triton X-100, 10 mM EDTA, 0.1 mg/mL lysozyme. A homogenizer was used to 
aid in the resuspension of the membrane pellet. Any undissolved pieces of membrane were 
pelleted at 100,000 g. at 4 °C for 30 minutes in the 45 Ti rotor. The supernatant containing 
dissolved BamCDE was collected and dialyzed overnight at 4 °C in 3.5 L TBS pH 8.0 with 0.5% 
Triton X-100. This dialysis step is to remove EDTA from the solution. The concentration of the 
dialyzed BamCDE solution was assessed, using dialysis buffer as a blank. 
 
3.6.5: Reconstruction of BamACDE-His for crystallographic studies 
The dialyzed BamCDE was mixed with the solution of folded BamA in a 10:1 BamCDE:BamA 
molar ratio in preparation for nickel column purification. 10 mL of Ni-NTA slurry was 
centrifuged at 10,000 g., the supernatant was discarded and the pelleted resin was washed three 
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times with 10 mL wash buffer (20 mM tris pH 8.0, 150 mM NaCl, 1% octyl glucopyranoside, 40 
mM imidazole, 1 mM TCEP). The BamACDE solution was mixed with the pelleted, washed 
resin and nutated at 4 °C for 30 minutes to bind the protein complex to the resin. This mixture 
was poured into a disposable, 30 mL plastic column, then the flow-through was collected and 
passed through the Ni-NTA resin a second time. The resin was washed twice with 25 mL of wash 
buffer and the protein complex was eluted using 7.5 mL elution buffer (20 mM tris pH 8.0, 150 
mM NaCl, 1% OG, 200 mM imidazole, 1 mM TCEP). The eluate was concentrated to roughly 1 
mL in a 100 kDa molecular weight cutoff filter, then passed through a Superdex 200 size-
exclusion column at 0.5 mL/minute using 20 mM tris pH 8.0, 150 mM NaCl, 1% OG, 1 mM 
TCEP in an isocratic elution. Fractions from the main peak were concentrated in a 100 kDa 
molecular weight cutoff filter. 
 
3.6.6: Limited proteolysis of the Bam Complex 
Chymotrypin and trypsin were dissolved in water to concentrations of 1000, 333, 111, 37, 12, and 
4 µg/mL. 2 µL of one protease was added to 22 µL of purified BamACDE and incubated at room 
temperature for 30 minutes. 8 µL 4X SDS loading buffer was added to the sample to quench the 
reaction, which was then vortexed and incubated at 95 °C. Samples were run in a 4-12% gradient 
polyacrylamide gel and stained with coomassie to visualize protein fragments. 
 
3.6.7: Overexpression and purification of ns-SeMet-BamA 
A 5X concentrated solution of salts for generating minimal M9 media was autoclaved: 64 g 
sodium phosphate penta-hydrate, 15 g potassium phosphate (dibasic), 2.5 g NaCl, 5 g ammonium 
chloride were added to 800 mL deionized water and the volume was brought to 1 L with water. 
After the media was autoclaved and cooled, sterile-filtered reagents were added: 2 mL 1 M 
magnesium sulfate, 100 µL 1 M CaCl2, and 20 mL 20% glucose. A 10 mL overnight culture of 
BL21 (DE3) harboring pCH103 was grown in LB with 50 µg/mL carbenicillin. The cells from 
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the overnight culture were pelleted at 5,000 g. for 10 minutes at 4 °C, then washed with 10 mL 
minimal M9 media and used to seed 1 L minimal M9 media. This was shaken at 37 °C and grown 
overnight. The following morning, the culture had grown to OD600=1.2. 50 mg selenomethionine, 
100 mg lysine-HCl, 100 mg threonine, 100 mg phenylalanine, 50 mg leucine, 50 mg isoleucine, 
and 50 mg valine were added to the culture. 15 minutes later, protein expression was induced 
with 1 mM final concentration IPTG and grown for an additional 8 hours at 37 °C. The cells were 
pelleted at 5,250 g. for 10 minutes at 4 °C and the pellets were flash-frozen in liquid N2 for 
overnight storage at -80 °C. The selenomethionine-labeled ns-BamA was refolded and purified 
according to the protocol for unlabeled BamA as described in 3.6.3.  
 
3.6.8: Lysine methylation of the Bam complex 
BamCDE-His and ns-BamA were purified according to the methods described in 3.6.4 and 3.6.3. 
10 mL Ni-NTA resin slurry was applied to a plastic chromatography column and equilibrated 
with 2X 25 mL wash buffer (1% n-octyl-β-D-glucopyranoside, 50 mM HEPES pH 8.0, 150 mM 
NaCl, 40 mM imidazole). Purified, refolded ns-BamA was mixed with BamCDE-His in a 1:10 
molar ratio and passed through the column two times to enhance the amount of protein complex 
binding to the resin. 2X 25 mL of wash buffer was passed through the column and the protein 
complex was eluted using 7.5 mL elution buffer (1% n-octyl-β-D-glucopyranoside, 50 mM 
HEPES pH 8.0, 150 mM NaCl, 200 mM imidazole.  The eluate was concentrated in a 100 kDa 
molecular weight cut-off filter to a volume of approximately 1 mL, then run isocratically through 
a Superdex 200 column on an FPLC with a running buffer composed of 50 mM HEPES pH 8.0, 
150 mM NaCl, 1% n-octyl-β-D-glucopyranoside to remove imidazole from the sample. Fractions 
corresponding to the main peak were concentrated to 1 mg/mL in a 100 kDa molecular weight 
cut-off filter. For every mL of protein solution, 20 µL 1 M dimethylamine-borane complex and 
40 µL 1 M formaldehyde were added. The solution was mixed gently and incubated at 4 °C for 2 
hours. At that point, an additional 20 µL 1 M dimethylamine-borane complex and 40 µL 1 M 
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formaldehyde were added for every 1 mL of protein solution and the reaction was nutated at 4 °C 
overnight. The following morning, the alkylation reaction was quenched using an excess of TBS 
pH 8.0, 1% n-octyl-β-D-glucopyranoside, 1 mM TCEP. This solution was concentrated to 600 µL 
in a 100 kDa molecular weight cut-off filter and centrifuged at 4 °C for 10 minutes at 10,000 g. to 
pellet any precipitated protein. The supernatant was removed and applied to a Superdex 200 
column on an FPLC. The protein was eluted using an isocratic method, with the running buffer 
composed of 20 mM tris pH 8.0, 150 mM NaCl, 1% n-octyl-β-D-glucopyranoside, 1 mM TCEP at 
a flow rate of 0.5 mL/min. Fractions corresponding to the main peak were collected and 
concentrated in a 100 kDa molecular weight cut-off filter to the concentration desired for 
crystallographic experiments. 
 
3.6.9: Preparation of Bam complex bicelles 
A 25% w/v solution of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and CHAPSO 
bicelles was prepared by mixing 375.3 mg DMPC with 124.7 mg CHAPSO (a 2.8:1 molar ratio), 
which was subsequently diluted with water. This suspension was heated at 60 °C and cooled on 
ice repeatedly, with frequent vortexing, until the lipids had dissolved into solution. At room 
temperature, this solution forms a gel, while near 4 °C the solution becomes much less viscous. 
To make the protein bicelles, the bicelle solution was put on ice until the gel became a liquid, at 
which point the bicelle solution was added to a solution of 12 mg/mL Bam complex in a 1:4 
volume ratio, bringing the final bicelle concentration to 5%. This solution was kept on ice for at 
least 30 minutes and used within several hours to set crystallization trays at room temperature. 
 
3.6.10: Crystallization 
Purified Bam complex was concentrated to the appropriate concentration (5-20 mg/mL) in a 100 
kDa molecular weight cut-off filter and dispensed into 96-well MRC3 crystallization trays from 
Hampton Research using a Formulatrix NT8 liquid handler. A reservoir volume of 30 µL was 
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pipetted and crystallization drops ranged in volume from 200 nL to 1 µL, with variable protein 
solution:reservoir solution ratios present in the drop. Plates were stored at 4 °C or 20 °C and 
imaged at regular intervals over the course of a month. When scaling up crystallization 
conditions, trays were set by hand in CrysChem 24-well trays, using reservoir volumes of 500 µL 
and drop volumes ranging from 1 µL to 4 µL with various protein volume to reservoir volume 
ratios. 
 
3.6.11: Collection and analysis of X-ray diffraction data 
Crystals were screened for diffraction at 100 K on the 24-ID-E beamline at the Advanced Photon 
Sources (APS) at the Argonne National Laboratory in Chicago, Illinois. Initial screening for 
diffraction was done with a 40 µm diameter beam at 40% transmission, taking one pair of 
exposures for indexing purposes. When crystals did not show significant radiation damage, full 
360° datasets were collected. Otherwise, collection recommendations from the beamline software 
RAPD were followed to obtain datasets. Indexing and scaling of data was performed in XDSGUI 
and freeR flags were appended to the data using the Import software in the CCP4 software suite. 
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Chapter 4: Cocrystallization of Staphylococcus aureus PBP2 with 













The cell wall of Gram-negative and Gram-positive bacteria is composed of polysaccharide 
strands that are heavily crosslinked with peptide bridges. This macromolecular mesh, called 
peptidoglycan (PG), protects the cell from osmotic stress. In Gram-positive bacteria, the PG cell 
wall resides extracellularly and its thickness ranges from about 20 nm to 50 nm, as revealed by 
electron micrographs.1 A set of essential enzymes, peptidoglycan glycosyltransferases (PGTs) 
and transpeptidases (TP), synthesize PG. Because the cell wall is necessary for cell viability, 
PGTs and TPs have received considerable attention as antibiotic targets.2 PGTs are responsible 
for creating the sugar polymer backbone and TP enzymes crosslink peptide moieties between 
sugar polymer strands (Figure 4.1). The substrates on which these enzymes act are Lipid II and 
oligomers of Lipid II, a diphospholipid-linked disaccharide pentapeptide that is synthesized on 
the intracellular side of the cell membrane and subsequently flipped to the extracellular space 








Figure 4.1. Biosynthesis of the cell wall. Lipid II monomers are polymerized 
by GT enzymes on the extracellular face of the cell membrane into higher-order 
sugar polymers, consisting of alternating N-acetylmuranic acid (NAM) and N-
acetylglucosamine (NAG) sugars. TP enzymes catalyze the crosslinking of 
these polymers through peptide moieties to form an enormous mesh. Figure is 
from ref. 11. 
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PGTs are divided into two classes: 1) bifunctional PGTs consisting of an N-terminal PGT domain 
that is linked to a C-terminal TP domain, a class of proteins that are known as penicillin-binding 
proteins (PBPs) and 2) monofunctional PGTs that do not contain a TP domain.4 An immobilized 
β-lactam antibiotic such as penicillin pulls down bacterial PBPs, a trait that gave rise to the name 
of this class of enzymes.5 β-lactams react with a serine residue in the active site of the TP domain 
of PBPs, forming a covalent acyl-enzyme adduct that irreversibly inhibits TP function. Although 
many β-lactam antibiotics have been developed over the last ninety years, bacteria have evolved 
β-lactamase enzymes, which hydrolyze the β-lactam ring of the antibiotic, rendering it inactive. 
On the other hand, only one small molecule natural product, moenomycin A (Figure 4.3, top), has 
been found to bind to the PGT domain of a PBP or a monofunctional PGT.6 Moenomycin A is an 
incredibly potent inhibitor of PGT activity with single digit nanomolar affinity, but its poor oral 
bioavailability prevents it from being a clinically-useful antibiotic.7  
 
Staphylococcus aureus expresses only one bifunctional penicillin-binding protein called PBP2. 
PBP2 consists of an N-terminal cytoplasmic tail, a transmembrane domain, a globular PGT 
domain, and a C-terminal TP domain. PBP2 is of particular interest because a naturally-occurring 
mutant form of the protein, PBP2a, renders the organism resistant to β-lactam antibiotics, 
including methicillin. The active site of PBP2a has a lower affinity for β-lactams than PBP2 and 
the rate of acylation of PBP2a’s active site serine is much slower in PBP2a than in PBP2.8 The 
name given to strains of S. aureus bearing this mutant allele is methicillin-resistant 
Staphylococcus aureus (MRSA), which can be particularly dangerous. Blood infections with 
MRSA result in death in 20-40% of patients.9 Since the TP domain of PBP2a is immune to β-
lactam antibiotics and the PGT domains of PBP2 and PBP2a very closely resemble each other, 
the development of a small molecule inhibitor of the PBP2/PBP2a PGT domain would be 










Several crystal structures of wild-type PBP2 have been reported and a crystal structure of 
moenomycin bound to the PGT domain of PBP2 has also been published (Figure 4.2).10-13 Based 
on crystal structures of PBP2 in complex with moenomycin A, a former postdoctoral researcher 
in the Kahne Group, Dr. Christian Gampe, developed a fluorescently-labeled, truncated analog of 
moenomycin A that bind to the PBP2 PGT domain at the same location as the untagged form of 
moenomycin A (Figure 4.3).14 They identified the minimal pharmacophore of moenomycin A 
(black) and conjugated this molecule with fluorescein. The fluorescently-labeled moenomycin 
derivative was used in fluorescence polarization assays to identify potential PGT inhibitors. The 
assay relies on the small molecule probe tumbling slowly in solution when it is bound to a large 
macromolecule like PBP2 and the unbound probe tumbling at a greater rate. A slowly-tumbling 
fluorophore will reemit polarized light in the same direction as the incoming light to a greater 
extent than a quickly-tumbling fluorophore. Thus, small molecules that displace the fluorescent 
probe from PBP2 are identified by a decrease in polarization.15 
Figure 4.2. Cartoon representation of PBP2(59-716)-His6, lacking its 
cytoplasmic and transmembrane domains, bound to moenomycin. The protein 
in colored from N- (blue) to C- (red) terminus. The PGT domain is depicted on 











4.2: Crystallization of PBP2 with putative PGT inhibitors 
In collaboration with scientists at Evotec, several small molecule inhibitors of PBP2 were found 
using the fluorescence displacement assay described above (Figure 4.4). Aside from displacing 
the fluorescent moenomycin probe developed by Gampe et al. in vitro, the molecules had 
minimum inhibitory concentrations in S. aureus between 0.5 µg/mL and 8.0 µg/mL in vivo, 
suggesting that they could bind to the PGT domain of PBP2, inactivating it and causing cell 
death. All molecules other than the phosphate-derivatized molecule D in figure 4.4 were very 
insoluble in water, but all of the molecules were soluble in DMSO. 
Figure 4.3. Moenomycin A (top) and the small-molecule probe for fluorescence 
polarization assays (bottom). The pharmacophore of moenomycin is in black, 
regions of the molecule that do not contribute to PGT binding are in grey, and 
the red arrows indicate regions of moenomycin that are important for binding to 








We aimed to obtain a crystal structure of PBP2 bound to a small molecule inhibitor identified in 
this screen. We were interested in recreating the PBP2 crystals reported by Lovering et al. before 
attempting to cocrystallize small molecules with PBP2. We used the same PBP2(59-716)-His6 
construct that had been reported, which lacks the N-terminal transmembrane domain, resulting in 
cytoplasmic expression of the protein.13 In brief, PBP2(59-716)-His6 was overexpressed at 15 °C 
in S. aureus overnight, cells were lysed, whole cells were pelleted, and the supernatant was 
passed through Ni-NTA resin. PBP2(59-716)-His6 was eluted from the nickel column, passed 
Figure 4.4. Small molecules identified as potential inhibitors of PBP2 PGT 
activity from a fluorescence displacement assay using a truncated, fluorescein-




through a Superdex 200 size-exclusion column, and finally purified by anion-exchange 
chromatography on a MonoQ column (Figure 4.5). Purified PBP2(59-716)-His6 was concentrated 
to 18 mg/mL and pipetted by hand into 0.5 µL protein solution + 0.5 µL reservoir solution (100 
mM HEPES pH 7.0, 0.55 M KCl, 9% (w/v) PEG 8000) drops in a ChrysChem 24-well sitting 










Figure 4.6. PBP(59-716)-His6 crystals grown in 100 mM HEPES pH 7.0, 0.55 
M KCl, 9% (w/v) PEG 8000. A. Fanned, overlapping crystal plates rarely grew 
to the ~75 µm long crystals shown here. B. More frequently, a shower of crystal 
pinwheels formed. Crystals were grown by Jeep Srisuknimit. 
A B 
Figure 4.5. A. Size-exclusion chromatogram of PBP2(59-716)-His6 purification 
on Superdex 200 column. B. Anion-exchange chromatogram of PBP2(59-716)-





Crystals were cryoprotected by serial addition of mother liquor containing 20% ethylene glycol to 
the crystal drop, through which the PBP2(59-716)-His6 crystals were picked. Crystals were 
immediately flash-frozen in liquid N2 and irradiated at 100 K at APS. Results from a 2.9 Å 
dataset are presented in Figure 4.7 and Table 4.1, though ice formation during freezing occurred 




Figure 4.7. A. PBP2(59-716)-His6 crystals mounted on the 24-ID-E line at 
APS. Crystals froze clear. B. A representative frame from a 2.9 Å dataset. 









Because we were recreating the crystallization condition of PBP2(59-716)-His6 that had been 
reported previously, APS beamline software was able to solve the dataset presented in Table 4.1 
automatically by molecular replacement. The space group into which our protein packed and the 
unit cell dimensions of the crystal matched those of the apoenzyme structure reported 
previously.13 Having reproduced high-resolution crystals of PBP2(59-716)-His6, we began 
Table 4.1. Crystallographic parameters and statistics for the dataset from which 
Figure 4.7 B. was generated.  
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cocrystallization and soaking experiments with the small molecules presented in Figure 4.4. and 
Lipid II monophosphate, which has been shown to inhibit PBP2 in vitro.16 General methods were 
informed by work reported by Hassell et al.17 
 
All but one of the small molecules provided by the researchers at Evotec were insoluble in water, 
which made soaking them into crystals or setting up cocrystallization experiments particularly 
difficult. The addition of DMSO-dissolved compound A, B, C, or E to a solution of protein 
caused the compound to crash out of solution immediately. Despite these difficulties, we took 
several approaches to obtain PBP2(59-716)-His6 cocrystals with the small molecules. 1) Protein 
solutions were nutated overnight with an inhibitor at a 1:1, 1:2, 1:5, or 1:10 protein:inhibitor 
molar ratio. Although the putative inhibitors crashed out, we hypothesized that enough of the 
small molecule would dissolve into solution and associate with the protein. The following 
morning, undissolved compound was pelleted, the protein was concentrated to 18 mg/mL, and 
crystal trays were set. 2) We found that the addition of DMSO-dissolved inhibitor to a crystal 
drop did not disrupt the already-formed crystals, although the added small molecule quickly 
precipitated. Because the crystals themselves appeared stable, we set up soaking experiments. A 
putative inhibitor was diluted in DMSO so that a 0.5 µL addition of the solution to a crystal drop 
would deliver the small molecule in a 10:1 inhibitor:protein molar ratio. These crystallization 
wells were resealed and incubated for up to 24 hours before crystals were cryoprotected and 
flash-frozen. 3) Finally, we performed fast soaks by serially transferring a crystal into 
increasingly concentrated cryoprotectant solutions containing one of the putative inhibitors. This 
gave the crystal exposure to dissolved compound for less than one minute. Crystals were picked 
from the final cryoprotectant solution and flash-frozen in liquid N2. Although many small crystals 
formed from the screening methods listed above none diffracted to a resolution comparable to 
that of the published apoenzyme structure and no structures were able to be solved from datasets 




PBP2(59-716)-His6 does not reliably crystallize under the conditions reported above. Based on 
grid screening of PBP2(59-716)-His6 crystallization conditions, the protein remains stable at high 
concentrations and may have a greater propensity to form crystals if it is crystallized above 20 
mg/mL. Likewise, cryoprotecting the PBP2(59-716)-His6 crystals using the method reported in 
section 4.2 nearly always causes ice crystals to form during flash-freezing. Extensive screening of 
cryoprotectants and alternative methods of cryoprotection are required in order to find conditions 
that will freeze clear. 
 
The results presented in this chapter represent a small step toward the development of PBP 
inhibitors that affect the function of the PGT domain of PBP2. Further small molecule screening 
using the moenomycin A probe in Figure 4.3 could lead to the discovery of additional small 
molecule inhibitors. Moenomycin A is the only known small molecule to inhibit this essential 
function of PBPs, but due to its poor pharmacological features, finding an alternative would be of 
great service to human health. Crystal structures of novel PGT inhibitors bound to PBP2 would 
show if the inhibitory mechanism of moenomycin A is the preferred binding mode or if there are 
alternative sites for inhibiting the protein’s activity. These studies would enable the development 











4.4: Materials and methods 
4.4.1: Materials 
Unless stated otherwise, all chemicals were obtained from Sigma Aldrich and, unless specified 
otherwise, all cultures were grown in lysogengy broth (LB) obtained from Difco, with antibiotics 
at a concentration of 50 µg/mL. Cultures were grown in Innova 44 incubators and pelleted using a 
Beckman Coulter J6-Mi floor centrifuge or a 5810 R desktop centrifuge from Eppendorf. Ni-
NTA resin for protein purifications was obtained from Qiagen. Affinity chromatography was 
performed in Poly-Prep Chromatography Columns from Bio-Rad. Protein concentrations were 
determined using a Thermo Scientific NanoDrop 2000 UV/vis spectrometer. Purification of PBP2 
was performed on a GE AKTA Pure FPLC using a Superdex 200 10/30 GL gel filtration column 
and a MonoQ 5/50 GL anion-exchange column. E. coli phospholipids for the formation of 
proteoliposomes were purchased from Avanti. Homogenization of membrane pellets and 
inclusion bodies was performed using an IKA T18 basic ULTRA-TURRAX homogenizer.  
 
4.4.2: Overexpression and purification of PBP2 
12 X 1.5 L LB were autoclaved and a 200 mL culture of LB with 50 µg/mL kanamycin was 
seeded with an S. aureus strain expressing PBP2(59-716) for overnight growth. The following 
morning, 1.5 mL 50 mg/mL kanamycin was added to each 1.5 L flask, which were each 
inoculated with 15 mL of the overnight culture. Cells were grown at 37 °C, shaking, until 
OD600=0.4-0.5, at which point the incubator’s temperature was reduced to 15 °C. Once the 
temperature of the shaker equilibrated to 15 °C, 750 µL of 1 M IPTG was added to each flask to 
induce protein expression. Cells were grown overnight and pelleted the following morning at 
5,000 g. for 15 minutes at 4 °C. Cells were resuspended in TBS pH 8.0 and repelleted at 5,000 g. 
for 15 minute at 4 °C. Cell pellets were resuspended in 40 mL 10 mM tris pH 8.0, 1 M NaCl, 10 
mM MgCl2, 10% v/v glycerol, 40 mM CHAPS, 100 µg/mL DNase, and 1 mM PMSF. Cells were 
lysed by 3 passes through a cell disrupter at 15,000 psi and any unlysed cells were pelleted by 
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ultracentrifugation at 37,000 g. for 30 minutes at 4 °C. 3 mL Ni-NTA resin was loaded onto a 
plastic Poly-Prep column and equilibrated with 2X 25 mL wash buffer (10 mM tris pH 8, 200 
mM NaCl, 40 mM imidazole, and 0.28 mM LDAO). The supernatant from the ultracentrifugation 
run was passed through the Ni-NTA resin twice and the resin was washed with 2X 25 mL wash 
buffer. Protein was eluted with 30 mL elution buffer (10 mM tris pH 8, 200 mM NaCl, 200 mM 
imidazole, and 0.28 mM LDAO). This eluate was concentrated to ~7-10 mL in a 50 kDa 
molecular weight cut-off filter at 4,000 and 4 °C. 1 mL injections onto a Superdex 200 column, 
with an isocratic run using 20 mM imidazole, 10 mM tris pH 8, 0.28 mM LDAO as the running 
buffer removed imidazole from the protein solution and any contaminating proteins. Fractions 
from this size-exclusion run were concentrated in a 50 kDa molecular weight cut-off filter until 
the protein concentration was ~8 mg/mL. A MonoQ 5/50 GL column was equilibrated with 
running buffer (10 mM tris pH 8, 0.28 mM LDAO) and the concentrated size-exclusion fractions 
were injected onto the column 1 mL at a time. Line A was connected to running buffer and line B 
was connected to elution buffer (10 mM tris pH 8, 0.28 mM LDAO, 500 mM NaCl). The run 
conditions for anion exchange were as follows, with the flow rate at 1 mL/min.: 1) 5 mL 100% 
wash buffer, 2) 10 mL of sample application with 100% wash buffer, 3) 3 mL linear gradient to 
10% elution buffer, 4) 25 mL linear gradient to 14% elution buffer, 5) 5 mL linear gradient to 
40% elution buffer, 6) 5 mL linear gradient to 100% elution buffer, 7) 5 mL 100% elution buffer, 
and 8) 10 mL 100% wash buffer to reequilibrate the column. The largest peak corresponded to 
PBP2(59-716), which eluted at ~60 mM NaCl. Fractions corresponding to this peak were 




Purified PBP2 was concentrated to 18 mg/mL in a 50 kDa molecular weight cut-off filter and 
dispensed by hand into CrysChem 24-well trays, using reservoir volumes of 500 µL and drop 
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volumes ranging from 1 µL to 4 µL with protein volume to reservoir volume ratios of 1:1, 1.5:1, 
and 2:1. Trays were set at room temperature and crystals were grown for several days.  
 
4.4.4: Collection and analysis of X-ray diffraction data 
Crystals were screened for diffraction at 100 K on the 24-ID-E beamline at the Advanced Photon 
Sources (APS) at the Argonne National Laboratory in Chicago, Illinois. Initial screening for 
diffraction was done with a 40 µm diameter beam at 40% transmission, taking one pair of 
exposures for indexing purposes. When crystals did not show significant radiation damage, full 
360° datasets were collected. Otherwise, collection recommendations from the beamline software 
RAPD were followed to obtain datasets. Indexing and scaling of data was performed in XDSGUI 
and freeR flags were appended to the data using the Import software in the CCP4 software suite. 
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ABSTRACT: The Bam machine assembles β-barrel mem-
brane proteins into the outer membranes of Gram-negative
bacteria. The central component of the Bam complex, BamA, is
a β-barrel that is conserved in prokaryotes and eukaryotes. We
have previously reported an in vitro assay for studying the
assembly of β-barrel proteins by the Bam complex and now
apply this assay to identify the speciﬁc components that are
required for BamA assembly. We establish that BamB and
BamD, two lipoprotein components of the complex, bind to
the unfolded BamA substrate and are suﬃcient to accelerate its
assembly into the membrane.
The outer membranes (OMs) of Gram-negative bacteriacontain transmembrane proteins with β-barrel structure.
These proteins are synthesized in the cytoplasm with N-
terminal signal sequences, which target them for secretion
across the inner membrane (IM) via the Sec machine.1−3 They
are then transported in complex with chaperones across the
aqueous periplasmic compartment between the membranes and
are ﬁnally assembled in the OM by the β-barrel assembly
machine (Bam).4 The Escherichia coli Bam complex contains
two proteins that are essential for cell viability: an integral
membrane β-barrel, BamA, and an OM lipoprotein, BamD,
which is anchored to the membrane by an N-terminal lipid and
which binds to the soluble region of BamA that extends into the
periplasm.5−7 Three other lipoproteins, BamB, -C, and -E,
associate with these two proteins but are not essential.5,8−10
The mechanism of β-barrel assembly is believed to be highly
conserved because orthologs of BamA are found in all
organisms that contain β-barrels.11−16 However, very little is
known about how that mechanism proceeds; it is thought to
involve multiple steps, including substrate recognition, folding,
and membrane insertion, but it is not clear how the
components of the Bam complex accomplish those steps.
We have reconstituted the process of β-barrel assembly in
vitro from puriﬁed components and now make use of this
system to dissect the Bam complex and observe the eﬀects of its
individual components.17,18 We chose to study the assembly of
BamA because it is an essential outer membrane protein
(OMP), and given that its function is to assemble other OMPs,
we hypothesized that its assembly mechanism might reveal or
reﬂect aspects of how it functions in the more general OMP
assembly process. Through this analysis, we have determined
that BamB and BamD bind to unfolded substrates.
■ EXPERIMENTAL PROCEDURES
Protein Expression and Puriﬁcation. The methods used
to express and purify the proteins used in this study are
described in the Supporting Information.
Proteoliposome Preparation. Proteoliposomes contain-
ing the Bam complex and Bam subcomplexes were prepared by
the detergent dilution methods described previously.18 Brieﬂy,
E. coli phospholipids (40 μL of a 20 mg/mL sonicated aqueous
suspension) were added to the puriﬁed Bam complexes (200
μL of 10 μM solutions) in TBS (pH 8), 0.03% DDM, and 1
mM TCEP and incubated on ice for 5 min. These
phospholipid/detergent/protein complex mixtures were then
diluted with 8 mL of TBS (pH 8) and incubated on ice for 30
min. They were then ultracentrifuged at 300000g for 2 h at 4
°C. The pelleted proteoliposomes were resuspended in 200 μL
of TBS (pH 8). Empty liposomes were prepared in parallel with
these proteoliposomes by the same detergent dilution method,
simply omitting the Bam proteins. Liposomes and proteolipo-
somes that were not used immediately were ﬂash-frozen in
liquid nitrogen and stored at −80 °C.
Folding Assays. Folding into Bam Proteoliposomes. The
unfolded FLAG-BamA or FLAG-OmpA substrate was prepared
at a concentration of 5 μM in 8 M urea and then diluted 10-fold
into solutions containing empty liposomes or the Bam
proteoliposomes. The proteoliposomes were also diluted 4-
fold from their stock concentrations into these reaction
mixtures. A typical reaction mixture contained 2.5 μL of
liposomes or proteoliposomes, 6.5 μL of TBS (pH 8), and 1 μL
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of 5 μM substrate such that the ﬁnal concentrations of the
substrate and Bam complex were 0.5 and ∼2.5 μM,
respectively. If the experiment included a preincubation, the
substrate was ﬁrst diluted 10-fold from a 50 μM solution in 8 M
urea to a solution of TBS (pH 8) or puriﬁed SurA in TBS (pH
8) and incubated at 25 °C for 10 min. These preincubated
solutions were then diluted 10-fold into the proteoliposomes.
Unless noted otherwise in the ﬁgures, the concentrations of
SurA and the substrates were 50 and 5 μM, respectively, in the
preincubation and 5 and 0.5 μM, respectively, in the ﬁnal
reaction mixtures. Reactions were stopped after incubation at
25 °C for 60 min (unless noted otherwise in the ﬁgures) by
adding ice-cold 2× SDS sample loading buﬀer [125 mM Tris
(pH 6.8), 4% SDS, 30% glycerol, 0.005% bromophenol blue,
and 5% β-mercaptoethanol]. For the time course experiments,
aliquots of the reaction mixtures were removed at the indicated
time points, quenched by the same method, and kept on ice. All
quenched samples were subjected to sodium dodecyl sulfate−
polyacrylamide gel electrophoresis (SDS−PAGE) (4 to 20%
gel) at 150 V for 110 min at 4 °C. The proteins were
transferred from the gel to a PVDF membrane by semidry
transfer in 25 mM Tris-HCl and 192 mM glycine (pH 8.3) at
10 V for 1 h. The products of the reaction were detected by
immunoblotting with FLAG-HRP antibodies (used at a dilution
of 1:200000). The blot images were scanned, and ImageQuant
TL was used to calculate the densities of the observed bands.
The percent yields of folded protein were determined by
comparing the densities of the unfolded and folded bands in
each lane.
Folding in Detergent. FLAG-tagged substrate proteins were
prepared at a concentration of 5 μM in 8 M urea. They were
then diluted 10-fold into a solution of TBS (pH 8) and 0.5%
LDAO and incubated at 25 °C for 1 h. The folding reactions
were stopped with 2× SDS sample loading buﬀer. The
quenched samples were subjected to SDS−PAGE and
immunoblotted as described in the previous section.
Folded Chimeric BamA Aﬃnity Puriﬁcation. FLAG-
tagged wild-type and mutant BamA substrates were prepared at
a concentration of 100 μM in 8 M urea. These substrates were
then diluted 10-fold into TBS (pH 8) and 0.5% LDAO and
incubated at 25 °C for 60 min to allow their β-barrels to fold.
Concentrated, puriﬁed BamCDE-His6 complex was then added
to each of the folded substrates to a ﬁnal concentration of 10
μM. Aliquots of these mixtures were removed and used as
“input” samples for SDS−PAGE analysis. The remainder of
each mixture was subjected to Ni-NTA aﬃnity chromatography
in TBS (pH 8) and 0.05% DDM. Proteins in the eluates were
precipitated with 10% trichloroacetic acid and incubated on ice
for 30 min. These samples were then centrifuged at 18000g for
10 min at 4 °C, and the pellets were resuspended in 1 M Tris
(pH 8) and 2× SDS sample loading buﬀer. The input and these
“eluate” samples were subjected to SDS−PAGE on a 4 to 20%
gradient gel at 200 V for 45 min. The proteins were then
detected by staining with Coomassie blue.
Unfolded Substrate Aﬃnity Puriﬁcations. Urea-dena-
tured FLAG-BamA and FLAG-OmpA were prepared at a
concentration of 100 μM and subsequently diluted 10-fold into
a solution of soluble BamB-His6, BamD-His6, or BamE-His6 in
TBS (pH 8) and incubated at room temperature for 10 min.
The ﬁnal concentrations of the unfolded OMP and the soluble
Bam proteins were 10 and 100 μM, respectively. A small aliquot
of each of these mixtures was removed for use as an input
sample. The remainder of the mixture was subjected to Ni-
NTA aﬃnity puriﬁcation; after the material had been loaded on
the column, it was washed with TBS (pH 8) with 20 mM
imidazole, and the bound proteins were eluted in TBS (pH 8)
with 200 mM imidazole. Proteins in the eluates were
precipitated with 10% trichloroacetic acid and resuspended in
Figure 1. BamA can be folded by a minimal set of OMP assembly components. (A) Schematic of the experimental design. The puriﬁed Bam
complex is incorporated into liposomes composed of E. coli phospholipids, and unfolded FLAG-tagged BamA is added to these proteoliposomes
with or without a chaperone. (B) Urea and SurA maintain the folding competence of BamA equally well. FLAG-BamA was prepared in 8 M urea and
then diluted directly into empty liposomes or proteoliposomes containing the Bam complex, or the denatured substrate was ﬁrst incubated in
solutions of Tris-buﬀered saline (TBS) or SurA and then added. The ﬁnal concentrations of the substrate and SurA were 0.5 and 5 μM, respectively.
The reactions were stopped after 60 min, and the products were analyzed by SDS−PAGE and immunoblotting with anti-FLAG antibodies. (C) Bam
subcomplexes lacking the lipoproteins demonstrate activity similar to that of the complete complex in assembling full-length FLAG-BamA (U,
unfolded FLAG-BamA; F, folded FLAG-BamA).
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1 M Tris (pH 8) and 2× SDS sample loading buﬀer as
described in the previous section. The proteins in the input and
these eluate samples were separated by SDS−PAGE and
stained with Coomassie blue.
■ RESULTS
We began by identifying the minimal set of components that
are required to assemble a BamA substrate in vitro. The fact that
the OMP chaperones and some of the Bam proteins are
nonessential suggests that they are not required for the
assembly of all OMPs. We found that BamA can be assembled
in vitro without a chaperone (Figure 1A,B). We diluted urea-
denatured, FLAG-tagged BamA with or without SurA, a major
periplasmic chaperone,19−21 into proteoliposomes containing
the Bam complex.17,18 The reaction products were separated via
seminative SDS−PAGE, and the folded and unfolded forms of
the proteins were then visualized by immunoblotting with anti-
FLAG antibodies. (β-Barrels do not unfold in SDS unless they
are boiled; therefore, their folded and unfolded forms have
diﬀerent mobilities on SDS−PAGE. The FLAG tag on the
substrate BamA distinguishes it from the untagged BamA in the
complex.) The substrate did become less foldable in the
absence of solubilizing factors (i.e., in Tris-buﬀered saline), and
SurA maintained its folding-competent state. However, SurA
could be functionally replaced by urea (Figure S1 of the
Supporting Information). These results are consistent with in
vivo measurements demonstrating that BamA levels do not
decrease when surA is deleted.22−25 Therefore, the BamA
substrate can be delivered to the Bam complex in diﬀerent ways
without aﬀecting its assembly on the machine. Accordingly, we
proceeded with our in vitro analysis of the direct eﬀects of the
Bam complex components on this substrate in the absence of a
chaperone.
We found that no speciﬁc Bam lipoprotein is required to
assemble BamA in vitro; BamAB and BamACDE subcomplexes
both assembled BamA into proteoliposomes (Figure 1C and
Figure S2A of the Supporting Information).17 The BamAB
subcomplex is less eﬀective, but it appears that BamB can at
least partially substitute for BamCDE. Clearly, BamD is
essential in vivo, while BamB is not; therefore, these proteins
must have additional nonredundant functions that may relate to
the assembly of other OMP substrates. Given that BamA is the
only common component in the subcomplexes, we examined
whether the functions of the lipoproteins are critical in the
assembly mechanism or whether BamA alone is capable of
assembling more BamA. We compared the activities of
proteoliposomes containing just BamA or BamCDE to that
of BamACDE proteoliposomes to determine if BamA functions
cooperatively with the lipoproteins (Figure 2A and Figure S2B
of the Supporting Information). Surprisingly, the unfolded
BamA substrate assembled into proteoliposomes containing
only the BamCDE lipoproteins more eﬃciently than into
proteoliposomes containing only BamA. Therefore, the
assembly of an unfolded BamA molecule does not require a
preassembled BamA molecule in the membrane.
We considered an alternate explanation for the observed
folding in the BamCDE proteoliposomes in which the folded
BamA product might form a complex with BamCDE and
thereby produce a more active assembly machine. We
discounted this hypothesis because a BamA substrate that
cannot bind to the lipoproteins after it is folded is assembled
equally well by them (Figure 2B and Figure S3 of the
Supporting Information). The periplasmic region of BamA
contains ﬁve polypeptide transport-associated (POTRA)
domains. The most C-terminal of these, P5, is adjacent to
the β-barrel and known to bind to BamCDE.7 We generated
chimeric and truncated BamA substrates containing two
Figure 2. Bam lipoproteins are suﬃcient to facilitate BamA assembly. (A) The BamCDE lipoproteins facilitate FLAG-BamA assembly more
eﬀectively than BamA alone, but BamA and BamCDE function most eﬀectively as a complex. The assembly of FLAG-BamA into proteoliposomes
containing BamA, BamCDE, or BamACDE was monitored over the course of 2 h. Reactions were stopped at the indicated time points. Folding
yields were determined by comparing the densities of the folded and unfolded bands and plotted. (B) The chimeric BamAP12 substrate does not bind
to BamCDE after it is folded (left), but these lipoproteins do facilitate its assembly (right). The FLAG-tagged wild-type, chimeric (P12, P23, and
P34), and truncated (P45) BamA substrates were folded in detergent (0.5% LDAO) for 60 min; puriﬁed BamCDE-His6 lipoproteins were then
added, and the complexes were isolated by Ni-NTA aﬃnity chromatography (left). Unfolded FLAG-tagged BamA substrates were added to empty
liposomes or BamCDE proteoliposomes, and the folding reactions were stopped after 120 min (right) (F, folded FLAG-BamA construct).
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POTRA domains and the β-barrel domain. When the truncated
substrate containing POTRA domains 4 and 5 is folded in
detergent and then mixed with the BamCDE lipoproteins, it
can be copuriﬁed with the lipoproteins; the chimeric BamA
proteins containing other pairs of POTRA domains (P12, P23,
or P34) do not copurify with the lipoproteins. Nevertheless, the
BamCDE lipoproteins facilitate the assembly of the chimeric
BamAP12. We therefore favor a model in which the lipoproteins
directly and independently facilitate the assembly of the
unfolded BamA substrate (vide inf ra).
In vivo experiments have indicated that BamA assembly is
facilitated by the Bam complex.7,24 Our results do not
contradict those studies; the fact that the BamACDE complex
was more active than BamCDE clearly demonstrates that when
BamA is preassembled in a complex with the lipoproteins it
facilitates the assembly of more BamA. Given the diﬀerence in
the kinetics of the BamABCDE- and BamCDE-catalyzed
processes, the latter is unlikely to occur in a wild-type cell.
However, by dissecting the Bam complex in vitro, we were able
to observe the independent function of the BamCDE
Figure 3. BamB and BamD are individually suﬃcient to facilitate BamA’s self-assembly but are not suﬃcient to assemble OmpA. (A) Unfolded
FLAG-BamA or FLAG-OmpA was added to a detergent solution or to proteoliposomes containing BamB, BamD, or BamE. Reactions were stopped
after 120 min. (B) OmpA is assembled by the complete Bam complex without a chaperone. FLAG-OmpA was added directly to proteoliposomes or
preincubated in TBS or a 10-fold excess of SurA as described for Figure 1B.
Figure 4. Certain Bam lipoproteins bind unfolded BamA and OmpA. Urea-denatured FLAG-BamA or FLAG-OmpA was diluted into a detergent-
free solution containing a 10-fold molar excess of the indicated soluble, His-tagged Bam protein (lacking its N-terminal lipid anchor). Binding of the
unfolded OMP to the Bam protein was then assessed by its ability to copurify by Ni-NTA aﬃnity chromatography.
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lipoproteins. It seemed possible that the lipoproteins might
perform this same function in the context of the complete
complex, and we therefore began to characterize how they
assemble BamA to understand their mechanistic role.
We examined whether other OMPs can also be assembled by
the lipoproteins alone or if BamA is unusual in this regard. We
compared how the individual Bam lipoproteins aﬀect the
folding of BamA and OmpA, an abundant but nonessential
OMP (Figure 3). Individually, BamB and BamD both facilitated
BamA assembly in vitro, but BamE did not. (BamC could not
be puriﬁed individually in a stable form and consequently was
not examined.) Clearly, the lipoproteins must have an
important, direct eﬀect because BamA does not assemble
eﬃciently into empty liposomes or into BamE proteolipo-
somes. BamB and BamD must share a common function that
has a speciﬁc eﬀect on the BamA substrate. In contrast, none of
the lipoproteins was suﬃcient to fold OmpA, but this substrate
was assembled if the Bam complex was present in the
membrane (Figure 3 and Figure S4 of the Supporting
Information).26 Therefore, OmpA is not inherently unstable
in the membranes used here, and we attribute the diﬀerence in
the ability of BamA and OmpA to assemble to a diﬀerence in
the properties of the substrates. BamB and BamD have a clear
function in the folding process, but it is not suﬃcient to
assemble OmpA.
We hypothesized that the common function of BamB and
BamD relates to binding substrates at the OM as has been
suggested by some crystal structures and cross-linking experi-
ments.27−33 We examined whether the lipoproteins interact
directly with unfolded OMPs; urea-denatured BamA or OmpA
was mixed with an excess of soluble, His-tagged BamB, -D, or
-E and then aﬃnity-puriﬁed. Soluble constructs of BamB, -D,
and -E, which lack their N-terminal lipids, were used so that
detergents could be omitted from the experiment to prevent
folding of the substrates. BamA copuriﬁed with BamD-His, to a
lesser extent with BamB-His, and not at all with BamE-His
(Figure 4). Therefore, the lipoproteins likely facilitate the
assembly of the BamA substrate by binding to its unfolded
state. In that respect, they may act like other enzymes by
stabilizing a transient or intermediate state in the reaction
pathway, and accordingly, their function in assembling the
substrate does not involve or require binding to the ﬁnal
product (the folded state of BamA) as indicated by the
assembly of the BamAP12 substrate described above.
However, this direct interaction between the unfolded
substrate and the lipoproteins is not suﬃcient to produce
folding on its own. When soluble BamB or BamD was added to
empty liposomes, no folding of BamA was observed (Figure S5
of the Supporting Information), implying that the membrane
localization or orientation of the lipoproteins matters.
Furthermore, BamD bound unfolded OmpA, but in this case,
binding was not suﬃcient to produce folding of the substrate
OMP (Figures 3A and 4). OmpA does not partition into the
membrane even if it is bound near it. BamB and BamD are not
capable of completing OmpA’s assembly alone, but simply
binding unfolded BamA near the membrane is suﬃcient to
facilitate this substrate’s assembly. BamA may be unusual or
unique in its ability to assemble in a manner independent of
other components. We were able to exploit this property of
BamA to observe the individual functions of BamB and BamD
in vitro. This is an advantage of our in vitro system in that it
allows dissection of an essential machine; we do not have to
contend with the pleiotropic eﬀects of mutations and deletions
in vivo and can isolate the eﬀects of individual components.
■ DISCUSSION
Here we have shown that BamB and BamD can bind unfolded
substrates and that this function facilitates the assembly of
BamA. These lipoproteins likely interact with the unfolded
substrate in diﬀerent ways, but both are capable of facilitating
BamA assembly by localizing the unfolded substrate to the
membrane. Although BamD can also bind unfolded OmpA, it is
not suﬃcient to catalyze the assembly of this substrate in vitro.
We attribute this diﬀerence in assembly requirements to the
function of BamA. BamA may be able to assemble aided only
by the lipoproteins because it performs some of the OMP
assembly mechanism; the fact that it is conserved in all
organisms may reﬂect its role in the later folding and insertion
steps of β-barrel assembly. BamD alone cannot assemble
OmpA because this substrate relies on a preassembled BamA to
complete the later steps of its assembly.
Many OMPs have been shown to assemble spontaneously
into lipid bilayers in vitro, but their ability to do so depends
strongly on the lipid content of the artiﬁcial membranes.26,34,35
In vivo, however, all OMPs must assemble into the same
membrane. The inability of OmpA to assemble under the same
conditions as BamA (i.e., into a membrane containing only
BamB or BamD) suggests that the BamA substrate may possess
some additional or unusual features. We propose that the
structure of BamA in some way facilitates its own assembly
such that it is less reliant on a preassembled Bam complex than
other OMPs. This spontaneous assembly process is clearly
much less eﬃcient than the Bam complex-catalyzed process,
but it provides an intriguing solution to the “chicken and egg
problem”. Perhaps in a primitive organism, an ancestral BamA
protein assembled itself, and the other complex components
later evolved to adapt BamA to assemble more and diﬀerent
types of other OMPs. In turn, BamA became more reliant on
the other Bam components for its assembly, and the
spontaneous process became comparatively less eﬃcient and
important. By creating an eﬃcient catalyst for β-barrel
assembly, it also became possible to segregate β-barrels to a
single membrane by making the rate of their assembly into the
membrane containing the Bam complex dramatically faster than
that into an empty membrane.
By dissecting the Bam complex in vitro, we have identiﬁed a
substrate binding interaction that appears to be important in
BamA’s assembly. Our next step is to establish whether
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